A Group Case Protocol Entitled: S/P Exploratory laparotomy, Evacuation of Peritoneum, Perihepatic Packing, Central Venous Catheter Insertion via Right Femoral Vein Presented to the Faculty of the School of Health and Natural Sciences In Partial Fulfillment of the Requirements in Intensive Nursing Practicum (NCM 122) Submitted by: Labasan, Vhea Jocel Araneta, Marsha Lianne Fillag, Veannie Mejia, Julie Ann Oreña, Marian BSN 4B February 2023 TABLE OF CONTENTS PARTS PAGE I. 3P’s page 3 II. Brief Description page 6 III. Anatomy and Physiology page 9 IV. Pathophysiology page 13 V. Laboratory Results and Diagnostic Studies page 16 VI. PERSON Assessment page 50 VII. Drug Study page 61 VIII. Course in the Ward page 80 IX. Nursing Care Plan page 99 X. References page 105 3P’s I. A. PERSONAL PROFILE Name: Mr. N Gender: Male Age: 46 years old Birthday: September 23, 1976 Place of Birth: Bayombong, Nueva Vizcaya Address: Magsaysay, Bayombong, Nueva Vizcaya Civil Status: Married Religion: Roman Catholic Nationality: Filipino Ethnicity: Ilocano Dialect: Ilocano, Tagalog Educational Attainment: College Graduate Occupation: Foreman Weight: 85 kg Height: 5’8” BMI: 24.8 kg/m2 SIGNIFICANT OTHER Name: Mrs. M Relationship to the Patient: Husband Age: 45 years old Civil Status: Married Address: Magsaysay, Bayombong, Nueva Vizcaya Educational Attainment: College Graduate Occupation: Housewife DATA PRIOR TO HOSPITALIZATION Chief Complaint: Patient was driving a motorcycle and bumped himself into a tree, wherein his abdomen, particularly his right upper abdomen, was the part that got slammed into the tree. NOI: Motor Accident TOI: 9:30 PM POI: Busilac, Bayombong, Nueva Vizcaya DOI: January 23, 2023 Admitting Diagnosis: Motor Vehicular Accident Final Diagnosis: S/P Exploratory laparotomy, Evacuation of peritoneum, Perihepatic Packing, Central Venous Catheter insertion via right femoral vein Admitting Physician: Dr. A Date of Admission: January 23, 2023 Time of Admission: 10:00 PM Date of Discharge: January 29, 2023 Time of Discharge: 10:00 AM 3 B. HISTORY OF PRESENT ILLNESS Mr. N is a 46-year-old male who was rushed into Region II Trauma Medical Center, Bayombong, Nueva Vizcaya, via ambulance due to a motor vehicle accident on January 23, 2023, at around 10:00 in the evening. According to the patient’s significant other, his wife, Mrs. M, stated that her husband works at the TAM-AN Resort in Busilac, Bayombong, Nueva Vizcaya, as a contractual foreman in the renovation of the said resort. On Sunday evening, Mr. N informed his wife that he would be going home late because there would be a simple celebration with his coworkers after they worked, and they had a good conversation until they did not notice it was already late in the evening. Following that, at around 9:00 PM, they decided to call it a day. Mr. N decided to drive home with his motorcycle since he had no work to do the following day. On his way home, it suddenly began to rain, yet Mr. N still continued to drive home and drive fast at 80 kilometers per hour to pass through the rain, even though it was already a heavy rain. Then, on the road between Busilac Barangay Hall and Busilac Resort, there was a truck on the opposite road whose headlight was set on high beam. Mr. N got dazzled by the light and was confused about where he should drive his motorcycle, and since it was raining on that day while driving his motorcycle at 80 km/hr., he passed through a deep manhole cover and suddenly braked after passing through it and bumped himself into a tree, wherein his abdomen, particularly his right upper abdomen, was the part that got slammed into the tree. The vendors of the fruit stand that was near the accident area and who witnessed the accident immediately called the emergency rescue team. Upon arrival in the hospital at around 10:00 PM, the patient was in a groggy state with some abrasions on his right hand, both arms, right upper leg, left lower leg, and on his right cheek. He was immediately resuscitated by the nurses on duty following the ABC procedure. Initial vital signs were also taken, with a temperature of 35.8 °C, a respiratory rate of 38 counts per minute, a pulse rate of 129 beats per minute, an oxygen saturation of 90%, and a blood pressure of 60/40 mmHg. The patient suddenly became pale and had cool skin when touched. The patient was in hypovolemic shock, which is why the physician came up with the decision to transfuse one pack of red blood cells with a blood type of O+ through a central venous catheter by way of the patient’s right femoral vein for an emergency and fast access for blood administration. An oxygen was also administered at 10 lpm through a face mask as ordered by the Physician. The nurse on duty also administered 1 liter of PNSS to the patient’s right cephalic vein and was set on a fast drip. Upon central venous catheter insertion, the physician noticed that Mr. N was grimacing while holding his abdomen, and upon checking his abdomen, there was the presence of a large, bluish-purplish bruise. Upon assessment, the patient’s abdomen was swollen, and Mr. N rated it as 8/10 on the pain rating scale. Mr. N was immediately tested with a FAST ultrasound to determine the extent of the trauma to the patient’s abdomen. The ultrasound indicates that there was bleeding on his abdomen, but the physician cannot rule out where the source of the bleeding was due to the large amount of blood present in the patient's peritoneal cavity. The nurse on duty assessed the patient’s eye, verbal, and motor responses using the Glasgow coma scale with a score of 12, in which, in the eye opening response, the patient’s eyes open to verbal stimuli, command, and speech, in the verbal assessment, Mr. N responded in a conversational manner but with some disorientation and confusion, and in the motor response, the patient pulls his limb away from the painful stimulus. Following that, a complete blood count was ordered by the physician, and an electrocardiogram was also done on the patient. Due to the result of the FAST ultrasound, the physician came up with the decision to undergo the patient for an emergency exploratory laparotomy. After an hour of transfusion, at 12:00 in the morning, the patient was transferred to the operating room for an emergency exploratory laparotomy to perform the evacuation of blood in the peritoneal cavity of the patient and to locate where the source of the bleeding came from. During the procedure, the surgeon was able to evacuate the blood with a total volume of 980 ml and was also able to locate the source of the bleeding, wherein the liver got damaged, particularly on the right hepatic artery, which he graded as V with laceration and parenchymal disruption involving 75% of the hepatic lobe. That is why the surgeon came up with an intervention to perform perihepatic packing on the right upper quadrant of the liver to temporarily stop the bleeding using gauze laparotomy sponges. After packing, the patient was closed, and the pack was left on the patient’s liver for 48 hours. After the surgery, the patient was transferred to the ICU to be closely monitored and evaluated. An arterial blood gas test was also performed, and the result indicated that the blood pH was 7.20, which was decreased from the normal range. Vital signs were also taken, including a 4 temperature of 36.8 °C, a respiratory rate of 26 counts per minute, a pulse rate of 110 beats per minute, an oxygen saturation of 96%, and a blood pressure of 100/70 mmHg, which indicate that the patient is having metabolic acidosis. A sodium bicarbonate was then ordered and administered to the patient through an intravenous line. One pack of red blood cells was then again transfused to the patient through a central venous catheter by way of the patient’s right femoral vein. On January 26, 2023, at 8:00 a.m., vital signs were stable, with a temperature of 36.8 °C, a respiratory rate of 19 counts per minute, a pulse rate of 89 beats per minute, an oxygen saturation of 97%, and a blood pressure of 110/80 mmHg. Metabolic acidosis was resolved, and the patient’s prothrombin time was 12.5 seconds. The surgeon scheduled the patient for a second-look laparotomy at 10:00 AM for the removal of the packing from the patient’s liver. In the operating room, the abdomen was washed out, the packing was carefully removed from the right upper quadrant, and the right hepatic artery was avulsed and ligated. After the procedure, the patient was transferred to the surgery ward for recovery and further monitoring. C. HISTORY OF PAST ILLNESS According to the patient, he has a history of a motor vehicle accident when he was in his early twenties, which he describes as a minor accident when he rides a tricycle, in which he got a minor abrasion on his legs and arms. FAMILY HEALTH HISTORY According to Mr. N, their family has no history of liver disease. Although his father was an alcoholic, he drinks three times a week. On the other hand, her mother was diagnosed with hypertension in 2018 and is currently on a maintenance dose of Lisopril. Other than that, no other genetic or hereditary problems were mentioned. SOCIAL HEALTH STATUS The patient is a 46-year-old male in Erikson's psychosocial development stages of generativity vs. stagnation. The patient is a foreman. He was married to Mrs. M, a housewife, and they had three children together. The patient is an alcoholic, wherein he drinks three times a week to the extent that he will be exhausted, but he does not smoke. He sleeps for 5–6 hours, goes to bed at 11:00 PM, and wakes up at around 5:00–6:00 AM. The patient's body mass index is 24.8 kg/m2, which classifies him in a healthy weight range. According to him, he is fond of eating fatty foods and some vegetables. He also just drinks water—3–5 glasses a day. Mr. N got her first dose of the Aztrazeneca vaccine for COVID-19 disease on July 15, 2021, and his second dose the following month. He got his booster shot from Pfizer at the Capitol on May 2022. 5 II. BRIEF DESCRIPTION Definition The liver is the most regularly injured organ in blunt abdominal trauma. Given its large size in the abdominal cavity, it can also be frequently injured with penetrating abdominal injuries. Liver trauma can run the gamut of minor lacerations or capsular hematomas with minimal morbidity and mortality to hepatic avulsions with high mortality. Most hepatic injuries are minor and can be graded with the American Association for the Surgery of Trauma Hepatic Injury Scale. VI is Hepatic Avulsion Incidence Liver injuries make up approximately 5% of all trauma admissions. The liver is the most common solid organ injured in blunt trauma, and patients with hepatic injury usually have other concomitant injuries. Mortality from hepatic trauma depends on the degree of injury. Minor liver injuries make up most hepatic trauma, with 80% to 90% being grades 1 or II. Mortality increases with the grade of injury, and grade VI liver injuries are often fatal. Liver injury is the primary cause of death in severe abdominal trauma and has a 10% to 15% mortality rate. Etiology A traumatic liver injury is common in both blunt and penetrating abdominal injuries. The liver’s anterior location in the abdomen, its fragile parenchyma, and the relative ease in which Gleeson’s capsule is violated makes it susceptible to injury from blunt forces. Its fixed location under the diaphragm also makes it susceptible to shear forces from deceleration injuries. The vasculature in the liver is made up of large but thin-walled vessels with high blood flow. The mechanism of injury for blunt abdominal trauma is often due to motor vehicle accidents, pedestrian accidents, and falls. Farming and industrial accidents can also lead to a number of liver injuries. In addition, the anterior location and large size relative to other abdominal organs make it prone to injury in penetrating abdominal penetrating trauma from gunshot or stab wounds. The right lobe of the liver is the most commonly injured portion in both blunt and penetrating injuries. 6 Predisposing Factors ● ● ● ● ● ● Alcohol Drugs Distracted Driving Risky Driving Seat Belt Use Male Gender Clinical Manifestation An injured liver results in hemorrhaging (bleeding). The signs and symptoms of an injured liver include: ● ● ● ● ● ● ● ● Drop in blood pressure Tachypneic Tachycardic Pale Abdominal pain Guarding (holding hand over the area) Tenderness in the upper right part of the abdomen Right shoulder pain and signs of shock and blood loss Complications The overall incidence of complications is < 7% but can be as high as 15 to 20% in highgrade injuries. Deep parenchymal lacerations can lead to a biliary fistula or biloma formation. In biliary fistula, bile leaks freely into the abdominal or thoracic cavity. A biloma is a contained collection of bile similar to an abscess. Bilomas are typically treated with percutaneous drainage. For biliary fistulas, biliary decompression through endoscopic retrograde cholangiopancreatography (ERCP) is highly successful. Abscesses develop in about 3 to 5% of injuries, often because of devitalized tissue being exposed to biliary contents. Diagnosis is suspected in patients in whom pain, temperature, and white blood count (WBC) increase in the days after injury; confirmation is by CT. Abscesses are usually treated with percutaneous drainage, but laparotomy may be necessary when percutaneous management fails. Diagnostic Procedures ● ● ● Ultrasonography- Ultrasonography is a noninvasive procedure and highly operatordependent. Focused assessment by ultrasound for trauma (FAST) has been advocated in initial trauma evaluation. The purpose of this exam is to provide a quick bedside assessment. Computed tomography scan- CT scan is the first imaging study which gives relatively detailed delineation of solid organ injuries and retroperitoneal injuries as well. CT scan is the standard imaging study for patients following blunt trauma Focused assessment with sonography (FAST)- in trauma is a rapid bedside ultrasound examination performed by surgeons, emergency physicians, and paramedics as a screening test for blood around the heart or abdominal organs after trauma. Laboratory Procedures ● ● Rapid Antigen Test- Antigen tests are immunoassays that detect the presence of a specific viral antigen, which indicates current viral infection. Complete Blood Count- A complete blood count (CBC) is a blood test used to evaluate your overall health and detect a wide range of disorders, including anemia, infection and leukemia. 7 ● ● ● Hepatitis B Surface Antigen Test (HBsAg)- A "positive" or "reactive" HBsAg test result means that the person is infected with hepatitis B. This test can detect the actual presence of the hepatitis B virus (called the “surface antigen”) in your blood. PT/PTT- The prothrombin time (PT) test measures how quickly blood clots. The partial thromboplastin time (PTT) is mainly used to monitor a person's response to anticoagulant therapies. Blood typing- Blood typing is a fast and easy way to ensure that you receive the right kind of blood during surgery or after an injury. ● ● ● ● Serum Electrolytes- An electrolyte panel, also known as a serum electrolyte test, is a blood test that measures levels of the body's main electrolytes: sodium, chloride, potassium and bicarbonate. Urinalysis- Urinalysis is a test of your urine. It's used to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease and diabetes. A urinalysis involves checking the appearance, concentration, and content of urine. Fecalysis- The stool will be checked for color, consistency, amount, shape, odor, and the presence of mucus. The stool may be examined for hidden (occult) blood, fat, meat fibers, bile, white blood cells, and sugars called reducing substances. The pH of the stool also may be measured. Liver Function Test- also referred to as a hepatic panel, are groups of blood tests that provide information about the state of a patient's liver. Surgical Procedures Exploratory laparotomy is surgery to open up the belly area (abdomen). This surgery is done to find the cause of problems (such as belly pain or bleeding) that testing could not diagnose. It is also used when an abdominal injury needs emergency medical care. This surgery uses one large cut (incision). The provider can then see and check the organs inside the abdomen. If the cause of the problem is found during the procedure, then treatment is often done at the same time. Perihepatic packing is a surgical procedure used in connection with trauma surgery to the liver. In this procedure the liver is packed to stop non arterial bleeding, most often caused by liver injury. A central venous catheter (CVC) is a catheter placed into a large vein. It is a form of venous access. Placement of larger catheters in more centrally located veins is often needed in critically ill patients, or in those requiring prolonged intravenous therapies, for more reliable vascular access. Pharmacologic Management ● ● ● ● ● ● ● ● Sodium Bicarbonate- treatment of metabolic acidosis which may occur in severe renal disease and severe primary lactic acidosis. Epinephrine- Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase blood pressure in adult patients with hypotension. Norepinephrine- Norepinephrine injection is used to raise blood pressure in patients with severe, acute hypotension (short-term low blood pressure). Dopamine- Dopamine is a peripheral vaso stimulant used to treat low blood pressure, low heart rate, and cardiac arrest. Dobutamine- Dobutamine's inotropic effect increases contractility, leading to decreased end-systolic volume and, therefore, increased stroke volume. The increase in stroke volume leads to an augmentation of the cardiac output of the heart. Acetaminophen- This drug is used to treat mild to moderate pain Benzylpenicillin- Treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia. Tranexamic Acid- Tranexamic acid (sometimes shortened to txa) is a medicine that controls bleeding 8 III. ANATOMY AND PHYSIOLOGY Digestive System The digestive system is made up of the gastrointestinal tract—also called the GI tract or digestive tract—and the liver, pancreas, and gallbladder. The GI tract is a series of hollow organs joined in a long, twisting tube from the mouth to the anus. The hollow organs that make up the GI tract are the mouth, esophagus, stomach, small intestine, large intestine, and anus. The liver, pancreas, and gallbladder are the solid organs of the digestive system. Liver The liver is the largest organ in your body. It weighs about 3 pounds and is about the size of a football. It performs many functions essential for good health and a long life. Liver is an organ with many functions, your liver’s two main responsibilities in the process of digestion are to make and secrete bile and to process and purify the blood containing newly absorbed nutrients that are coming from the small intestine. Bile has two main purposes: to help absorb fats and to carry waste from the liver that cannot go through the kidneys. Functions of the Liver The liver is an essential organ of the body that performs over 500 vital functions. These include removing waste products and foreign substances from the bloodstream, regulating blood sugar levels, and creating essential nutrients. Here are some of its most important functions: ● ● ● ● ● ● ● ● Albumin Production: Albumin is a protein that keeps fluids in the bloodstream from leaking into surrounding tissue. It also carries hormones, vitamins, and enzymes through the body. Bile Production: Bile is a fluid that is critical to the digestion and absorption of fats in the small intestine. Filters Blood: All the blood leaving the stomach and intestines passes through the liver, which removes toxins, byproducts, and other harmful substances. Regulates Amino Acids: The production of proteins depend on amino acids. The liver makes sure amino acid levels in the bloodstream remain healthy. Regulates Blood Clotting: Blood clotting coagulants are created using vitamin K, which can only be absorbed with the help of bile, a fluid the liver produces. Resists Infections: As part of the filtering process, the liver also removes bacteria from the bloodstream. Stores Vitamins and Minerals: The liver stores significant amounts of vitamins A, D, E, K, and B12, as well as iron and copper. Processes Glucose: The liver removes excess glucose (sugar) from the bloodstream and stores it as glycogen. As needed, it can convert glycogen back into glucose. Anatomy of the Liver The liver is reddish-brown and shaped approximately like a cone or a wedge, with the small end above the spleen and stomach and the large end above the small intestine. The entire organ is located below the lungs in the right upper abdomen. It weighs between 3 and 3.5 pounds. 9 Structure The liver consists of four lobes: the larger right lobe and left lobe, and the smaller caudate lobe and quadrate lobe. The left and right lobe are divided by the falciform (“sickle-shaped” in Latin) ligament, which connects the liver to the abdominal wall. The liver’s lobes can be further divided into eight segments, which are made up of thousands of lobules (small lobes). Each of these lobules has a duct flowing toward the common hepatic duct, which drains bile from the liver. Parts The following are some of the most important individual parts of the liver: Common Hepatic Duct: A tube that carries bile out of the liver. It is formed from the intersection of the right and left hepatic ducts. Falciform Ligament: A thin, fibrous ligament that separates the two lobes of the liver and connects it to the abdominal wall. Glisson’s Capsule: A layer of loose connective tissue that surrounds the liver and its related arteries and ducts. Hepatic Artery: The main blood vessel that supplies the liver with oxygenated blood. Hepatic Portal Vein: The blood vessel that carries blood from the gastrointestinal tract, gallbladder, pancreas, and spleen to the liver. Lobes: The anatomical sections of the liver. Lobules: Microscopic building blocks of the liver. Peritoneum: A membrane covering the liver that forms the exterior. 10 The liver can be damaged as a result of impact (for example, a motor vehicle crash) or penetrating trauma (such as a knife or gunshot wound). Injuries may range from relatively small collections of blood (hematomas) within the liver to large tears that go deep into the liver. Because the liver has many large blood vessels, the main problem resulting from liver injury is severe bleeding. People with liver injury and severe bleeding have symptoms of shock, including a rapid heart rate, rapid breathing, and cold, clammy, pale or bluish skin. People also have abdominal pain and tenderness because blood in the abdomen irritates the abdominal tissue. When bleeding is severe, the abdomen may also be swollen. Cardiovascular system The cardiovascular system is sometimes called the blood-vascular, or simply the circulatory system. It consists of the heart, which is a muscular pumping device, and a closed system of vessels called arteries, veins, and capillaries. As the name implies, blood contained in the circulatory system is pumped by the heart around a closed circle or circuit of vessels as it passes again and again through the various "circulations" of the body. Blood Blood is a constantly circulating fluid providing the body with nutrition, oxygen, and waste removal. Blood is mostly liquid, with numerous cells and proteins suspended in it, making blood "thicker" than pure water. The average person has about 5 liters (more than a gallon) of blood. Components of Blood ● ● ● ● Plasma is the main component of blood and consists mostly of water, with proteins, ions, nutrients, and wastes mixed in. Red blood cells are responsible for carrying oxygen and carbon dioxide. Platelets are responsible for blood clotting. White blood cells are part of the immune system and function in immune response. Functions of the Blood Blood is unique; it is the only fluid tissue in the body. 11 ● ● ● ● ● ● ● Carrier of gasses, nutrients, and waste products. Oxygen enters blood in the lungs and is transported to cells. Carbon dioxide, produced by cells, is transported in the blood to the lungs, from which it is expelled. Ingested nutrients, ions, and water are carried by the blood from the digestive tract to cells, and the waste products of the cells are moved to the kidneys for elimination. Clot formation. Clotting proteins help stem blood loss when a blood vessel is injured. Transport of processed molecules. Most substances are produced in one part of the body and transported in the blood to another part. Protection against foreign substances. Antibodies help protect the body from pathogens. Transport of regulatory molecules. Various hormones and enzymes that regulate body processes are carried from one part of the body to another within the blood. Maintenance of body temperature. Warm blood is transported from the inside to the surface of the body, where heat is released from the blood. pH and osmosis regulation. Albumin is also an important blood buffer and contributes to the osmotic pressure of blood, which acts to keep water in the blood stream. Bleeding is the loss of blood. Bleeding may be: ● Inside the body (internally) ● Outside the body (externally) Bleeding may occur: ● Inside the body when blood leaks from blood vessels or organs ● Outside the body when blood flows through a natural opening (such as the ear, nose, mouth, vagina, or rectum) ● Outside the body when blood moves through a break in the skin When blood is lost, the body quickly pulls water from tissues outside the bloodstream in an attempt to keep the blood vessels filled. As a result, the blood is diluted, and the hematocrit (the percentage of red blood cells in the total amount of blood in the body, or blood volume) is redu 12 IV. PATHOPHYSIOLOGY 14 15 V. LABORATORY RESULTS AND DIAGNOSTIC PROCEDURES A. RAPID ANTIGEN TEST Disease Reporting Unit Department of Pathology Region II Trauma and Medical Center Date conducted: January 23, 2023 Patient name: Mr. N Age: 46 years old Address: Magsaysay, Bayombong, Nueva Vizcaya Gender: Male __ Case, confirmed outbreak __ Close contact, confirmed outbreak __ Case, closed or semiclosed institution __ Close contact or semiclosed institution ✔ Case, Limited RTPCR Capacity __ Close contact, limited RTPCR capacity __ Covid-19 symptomatic suspects who are eligible for admission to our facility Result: Negative Date/Time done: January 23, 2023 Nursing Consideration: BEFORE: ● Identifies the indication for RAT swab to be collected (to assist in the detection or surveillance of the COVID-19 virus) ● Collects the appropriate equipment required for procedure; swab, test device, extraction tube, buffer solution, facial tissues ● Performs hand hygiene and don correct PPE to perform procedure- gloves, gown, N95 mask, eye wear ● Engages with the patient and family using appropriate communication and personcentered care to discuss the procedure and ask COVID-19 screening questions ● Positively identifies the patient, explains procedure and gains consent for specimen collection +/- clinical holding using appropriate communication and person-centered care principles ● Check expiry dates on device and test solution. Remove the test device from the foil pouch prior to use. Place on a flat, horizontal and clean surface. Hold the buffer bottle vertically and fill the extraction tube with buffer fluid until it flows up to the “fill line” of the extraction tube (300 μl) ● Positions the patient appropriately. Utilized appropriate supports/and or therapeutic holding during the procedure DURING: ● Tilt the patient’s head back 70 degrees. Using a pencil grip insert swab less than one inch (about 2 cm) into nostril (until resistance is met at the turbinates) ● Rotate the swab five times against the nasal wall then slowly remove from the nostril. ● Using the same swab repeat the collection procedure with the second nostril ● Swirl the swab tip in the buffer fluid inside the extraction tube, pushing into the wall of the extraction tube at least five times and then squeeze out the swab by squeezing the extraction tube with your fingers ● Break the swab at the breakpoint and close the cap of extraction tub ● Open the dropping nozzle cap at the bottom of the extraction tube ● Dispense 5 drops of extracted specimens vertically into the specimen well (S) on the device. Do not handle or move the test device until the test is complete and ready for reading. AFTER: ● Close the nozzle and dispose of the extraction tube containing the used swab ● Start timer. The test takes 15 minutes to return a result and must be accurately timed using a timer (mobile phone or other). Do not interpret the test result BEFORE 15 mins or AFTER 20 min of starting the test. Dispose of the used device according to your local regulations and biohazard waste disposal protocol. ● Negative result: The presence of only the control line (C) and no test line (T) within the result window indicates a negative result ● Positive result: The presence of the test line (T) and the control line (C) within the result window, regardless of which line appears first, indicates a positive result. ● Invalid result: If the control line (C) is not visible within the result window after performing the test, the result is considered invalid. B. ROUTINE HEMATOLOGY Patient Name: Mr. N Age: 46 years old TEST Gender: Male RESULT Hgb 120 g/L Hct 30 vol % RBC Count 4.71x10^12/L WBC Count pH 6.9 x10^9/L 7.20 DIFFERENTIAL COUNT RESULT 0.57 0.34 0.06 0.03 TEST Nuetrophils Lymphocytes Monocytes Eosinophils Basophils Band/Stabs Immature cells Platelet count NRBC 300 x10^9/L RBC INDICES 86.7 fl 29.1 pg 336 g/L 13.7 % MCV MCH MCHC RDW Date/Time conducted: January 23, 2023 REFERENCE RATE M: 135-180 g/L F: 120-160 g/L M: 40-50 vol % F: 37-47 vol % 4.5-5.9X10^12/L 5-10 x10^9/L 7.35-7.45 REFERENCE RATE 0.40-0.70 0.20-0.40 0.00-0.06 0.00-0.07 0.00-0.01 0.00-0.01 150-450 x10^9/L 82.0-95.0 fl 27.0-31.0 pg 320-360 g/L 11.6-14.6% C. SEROLOGY IMMUNOLOGY Patient Name: Mr. N Age: 46 years old Gender: Male Requesting Physician: Hospital no: 33958 ASSAY HBsAG METHOD I.C.T Date/Time conducted: January 23, 2023 Area: ER General Surgery RESULT Non-reactive D. CLINICAL HEMATOLOGY Patient Name: Mr. N Age: 46 years old TEST Gender: Male RESULT Bands/Stabs Immature Cells Platelet Count Clotting Time Bleeding Time TEST Reticulocyte Count Date/Time conducted: January 23, 2023 REFERENCE RATE 0.00-0.05 150-450x10 3-6 min 1-5 min SPECIAL HEMATOLOGY RESULT 17 REFERENCE RATE 0.3-3.0% ESR Prothrombin Time Reactivated Partial Thromboplastin Time Aspartate Aminotransferase ALT TPAG D-Dimer 12.5sec 27.8 sec M: 0-20 mm/hr F: 0-30 mm/hr 11.7-15.3 sec 24-35 sec 45 U/L 47 U/L 8-33U/L 4-36U/L 0.40 ug/ml 0-0.50 ug/ml E. BLOOD TYPING Patient Name: Mr. N Age: 46 years old Gender: Male Requesting Physician: Test Blood Typing (ABO Forward + Rh) Date/Time Done: Med Tech Hospital no: 33958 Date conducted: January 23, 2023 Area: ER Result “O” Rh Positive Head, Blood Bank Section F. CLINICAL CHEMISTRY Patient Name: Mr. N Age: 46 years old Test Gender: Male Result BUN Creatinine Sodium Potassium 5.96 mmol/L 54.90 mmol/L 143.0 mmol/L 4.5 mmol/L Date conducted: January 23, 2023 Reference Value 2.5-6.1 46.0-92.0 135.0-145.0 3.5-5.5 Nursing Consideration: BEFORE: ● Tell the patient that the test requires a blood sample. ● Explain to the patient, who will perform the arterial puncture, when it will occur, and where the puncture site will be; radial, brachial, or femoral artery. ● Inform the patient that he may not need to restrict food and fluids. ● Instruct the patient to breathe normally during the test, and warn him that he may experience a brief cramping or throbbing pain at the puncture site. DURING: ● Use a heparinized blood gas syringe to draw the sample. ● Perform an arterial puncture or draw blood from an arterial line. ● Eliminate air from the sample, place it on ice immediately, and prepare to transport for analysis. AFTER: ● After applying pressure to the puncture site for 3 to 5 minutes and when bleeding has stopped, tape a gauze pad firmly over it. ● If the puncture site is on the arm, don’t tape the entire circumference because this may restrict circulation. ● If the patient is receiving anticoagulants or has a coagulopathy, apply pressure to the puncture site longer than 5 minutes if necessary. ● Monitor vital signs and observe for signs of circulatory impairment. 18 G. ROUTINE URINALYSIS Patient Name: Mr. N Test Components Color Transparency / Appearance Age: 46 years old Gender: Male Date conducted: January 23, 2023 Macroscopic Examination Result Normal Pathophysiological Basis Values Red Straw Yellow Indication: Abnormal Finding tinged to Amber in Significance: Many foods and medicines can affect the color of the Color urine. Urine with no color may be caused by long-term kidney disease or uncontrolled diabetes. Red urine can be caused by blood in the urine. Implication: Patient Mr. N, urine color has an abnormal finding of having a red tinged in color urine. This may indicate an abdominal injury Indication: Abnormal Finding Hazy Clear Significance: Cloudy urine can be caused by pus, blood, sperm, bacteria, yeast, crystals, mucus, or a parasite infection, such as trichomoniasis Implication: Patient Mr. N, has a urine transparency of having hazy appearance, this may indicate concentrated urine. pH 3 4-5.8 Indication: Below the normal values Significance: Some foods and medicines can affect urine pH. A high pH can be caused by severe vomiting, a kidney disease, some urinary tract infections and asthma. A low pH may be caused by severe lung disease, uncontrolled diabetes, aspirin overdose, severe diarrhea, dehydration, starvation, drinking too much alcohol, or drinking antifreeze. Implication: Patient Mr. N, has a below the normal findings of the pH level of the urine which indicates of an acidosis urine. Protein Negative Negative Indication: Normal Significance: Protein in the urine may mean that kidney damage, an infection, cancer, systemic lupus erythematosus (SLE), or glomerulonephritis is present. Implication: Patient Mr. N found out that there is no trace of protein which indicates having no proteinuria. 19 Glucose Test Components RBC / hpf WBC / hpf Epithelial Cells Urates / Phosphate 90 mg/dl 80-140 mg/dL Indication: normal values Significance: Glucose is the type of sugar found in blood. Normally there is very little or no glucose in urine. When the blood sugar level is very high, as in uncontrolled diabetes, the sugar spills over into the urine. Glucose can also be found in urine when the kidneys are damaged or diseased Microscopic Examination Result Normal Pathophysiological Basis Values Indication: Below the normal value 3.20 4.20-6.10 Significance: Red blood cells in the urine may be caused by kidney or bladder injury, kidney stones, a urinary tract infection (UTI), inflammation of the kidneys glomerulonephritis, a kidney or bladder tumor, or systemic lupus erythematous (SLE). Implication: Patient Mr. N, has low normal value findings of which had an indication of internal bleeding Indication: Abnormal Finding 1.32 Puss cells Significance: The presence of cells, urates and and bacteria epithelial Phosphates may mean that the should be sample is not as pure as it needs to absent in be. These cells do not mean there is urine Moderate a medical problem, but the doctor may ask the patient to give another urine sample. Implication: Patient Mr. N has a moderate to few findings. An indication of having a presence of Few puss cells, a sign of infection and inflammation. Nursing Consideration: BEFORE: ● Tell the patient that the test requires a urine sample ● Explain to the patient the procedure and instruct the patient to void directly into a clean, dry container. Sterile, disposable containers are recommended. Women should always have a clean-catch specimen if a microscopic examination is ordered. Feces, discharges, vaginal secretions and menstrual blood will contaminate the urine specimen DURING: ● Collect specimens into a disposable collection apparatus consisting of a plastic bag with an adhesive backing around the opening that can be fastened to the perineal area Depending on hospital policy, the collected urine can be transferred to an appropriate specimen container ● Cover all specimens tightly, label properly and send immediately to the laboratory AFTER: ● If a urine sample is obtained from an indwelling catheter, it may be necessary to clamp the catheter for about 15-30 minutes before obtaining the sample. Clean the specimen port with antiseptic before aspirating the urine sample with a needle and a syringe. ● Observe standard precautions when handling urine specimens. ● If the specimen cannot be delivered to the laboratory or tested within an hour, it should be refrigerated or have an appropriate preservative added 20 H. ROUTINE FECALYSIS Patient Name: Mr. N MACROSCOPIC EXAMINATION Color Consistency MICROSCOPIC EXAMINATION Fat neutral fat crystals and soaps Yeast TEST Ova or Parasite Occult Blood Malarial Smear Age: 46 years old RESULT Brown to Green ish Brown Gender: Male NORMAL FINDINGS Brown to Greenish Brown Formed Formed Colorless 18% and non-fatty acid stool Colorless 18% and non-fatty acid stool Date conducted: January 23, 2023 PATHOPHYSIOLOGICAL BASIS Indication: NormalFinding Significance: Normal, healthy stool ranges from a shade of brown to greenish brown. This may vary of food intake and lots of colorful foods. The color is the result of what a person eat and how much bile is it in stool. Implication: Patient, has a normal finding Indication: Normal Finding Significance: Healthy stool is usually considered a soft, formed bowel movement. The consistency changes could be caused by an infection, nutrients not being digested due to celiac disease or a problem with the pancreas, such as pancreatic cancer or pancreatitis Implication: Patient, has a normal finding None RESULT NORMAL FINDINGS None Negative Negative NURSING CONSIDERATIONS BEFORE: ⮚ Assess the patient’s level of comfort. Collecting stool specimen may produce a feeling of embarrassment and discomfort to the patient. ⮚ Encourage the patient to urinate. Allow the patient to urinate before collecting to avoid contaminating the stool with urine. ⮚ Avoid laxatives. Advise patient that laxatives, enemas, or suppositories are avoided three days prior to collection. Instruct a red-meat free and high residue diet. The patient is indicated for an occult blood test, must follow a special diet that includes generous amounts of chicken, turkey, and tuna, raw and uncooked vegetables, and fruits such as spinach, celery, prunes and bran containing cereal for two (2) days before the test. DURING: ● Instruct the patient to collect small amount directly into a clean, dry container. Sterile, disposable containers are recommended ● Depending on hospital policy, the collected urine can be transferred to an appropriate specimen container Cover all specimens tightly, label properly and send immediately to the laboratory AFTER: ⮚ Instruct patient to do hand washing. Allow the patient to thoroughly clean his or her hands and perianal area. Resume activities. The patient may resume his or her normal diet and medication therapy unless otherwise specified. 21 I. FAST ULTRASOUND Patient Name: Mr. N Age: 46 Gender: Male years old Access No: E22101500055 Procedure: Whole Abdomen Health Record: 039958 Requesting Physician: Clinical Info: Liver Blunt Trauma Findings: Date conducted: January 23, 2023 Ward: Surgery Modality: DR - The lungs are clear - The heart is not enlarged - The aorta is unremarkable - Diaphragm and sulci are intact - Other chest structures are intact Impression: - Unremarkable Cardio Pulmonary Findings Ms. RM, RT Rad Tech RD, MD Radiologist Nursing Considerations: BEFORE: Explain to the patient the purpose of the test. Tell him who will perform the test and where it will take place. Inform the patient that he will need to lie flat on a narrow bed, which slides into a large cylinder that houses the MRI magnets. Explain to the patient that MRI is painless and involves no exposure to radiation from the scanner. A radioactive contrast dye may be used, depending on the tissue being studied. Advise the patient that he will have to remain still for the entire procedure. Explain to the patient who is claustrophobic or anxious about the test’s duration that he will receive a mild sedative to reduce his anxiety or that he may need to be scanned in an open MRI scanner, which may take longer but is less confining. Tell him that he will be able to communicate with the technician at all times and that the procedure will be stopped if he feels claustrophobic. If contrast media will be used, obtain a history of allergies or hypersensitivity to these agents. Mark any sensitivities on the chart and notify the practitioner. Instruct the patient to remove all metallic objects, including jewelry, hairpins, and watches. Ask the patient if he has any implanted metal devices or prostheses, such as vascular clips, shrapnel, pacemakers, joint implants, filters, and intrauterine devices. If so, the test may not be able to be performed. Make sure that the patient or a responsible family member has signed an informed consent form. Administer the prescribed sedative if ordered. At the scanner room door, recheck the patient one last time for metal objects. DURING: Remind the patient to remain still throughout the procedure. Assess how the patient responds to the enclosed environment. Provide reassurance if necessary. Monitor the cardiac function for signs of ischemia (chest pressure, shortness of breath, or changes in hemodynamic status). AFTER: The nurse should be aware of these post-procedure nursing interventions after magnetic resonance imaging: Tell the patient that he may resume his usual activities as ordered. If the test took a long time and the patient was lying flat for an extended period, observe him for orthostatic hypotension. 22 Provide comfort measures and pain medication as needed and ordered because of prolonged positioning the scanner. Monitor the patient for the adverse reaction to the contrast medium (flushing, nausea, urticaria, and sneezing). J. CLINICAL CHEMISTRY Patient Name: Mr. N Requesting Physician: Dr. Yabres, MD TEST Age: 46 years Gender: old Male Hospital no: 33958 RESULT Date: January 23, 2023 Area: Surgery Ward REFERE NCE VALUE 14-0-36.0 U/L Aspertate Aminotransferase 59 U/L Alanine Aminotransferase 65 U/L 0.0-35.0 U/L Total Bilirubin 99.7 umol/L Direct Bilirubin 68.7 umol/L Bilirubin Unconjugated 31.0 umol/L 3.4222.23 umol/L 0.0-6.84 umol/L 0.0-18.81 umol/L 23 PATHOPHYSIOLOGIC AL BASIS Indication: Above the normal values Significance: ALT is an enzyme found in the liver that helps convert proteins into energy for the liver cells. When the liver is damaged, ALT is released into the bloodstream and levels increase. Aspartate transaminase (AST). AST is an enzyme that helps metabolize amino acids. Implication: Patient, has an above the normal value findings which may have an indication of elevated aspartate aminotransferase and alanine aminotransferase as enzymes that indicates liver damage or fatty liver and high concentrations in the blood. Indication: Above the normal values Significance: Bilirubin attached by the liver to glucuronic acid, a glucose-derived acid, is called direct, or conjugated, bilirubin. Bilirubin not attached to glucuronic acid is called indirect, or unconjugated, bilirubin. All the bilirubin in blood together is called total bilirubin. This is to examine an elevated plasma bilirubin Implication: Patient, has an above the normal value findings which may have an indication of higher levels of direct bilirubin in blood an indication that the liver isn't clearing waste and bilirubin properly and has common bile duct obstruction Alkaline Phospate 104.40 U/L 38.0126.0 U/L Nursing Considerations: BEFORE: ⮚ Tell the patient that the test requires a blood sample. ⮚ Explain to the patient, who will perform the arterial puncture, when it will occur, and where the puncture site will be; radial, brachial, or femoral artery. ⮚ Inform the patient that he may not need to restrict food and fluids. ⮚ Instruct the patient to breathe normally during the test, and warn him that he may experience a brief cramping or throbbing pain at the puncture site. DURING: ● Use a heparinized blood gas syringe to draw the sample. ● Perform an arterial puncture or draw blood from an arterial line. ● Eliminate air from the sample, place it on ice immediately, and prepare to transport for analysis. AFTER: ⮚ After applying pressure to the puncture site for 3 to 5 minutes and when bleeding has stopped, tape a gauze pad firmly over it. ⮚ If the puncture site is on the arm, don’t tape the entire circumference because this may restrict circulation. ⮚ If the patient is receiving anticoagulants or has a coagulopathy, apply pressure to the puncture site longer than 5 minutes if necessary. ⮚ Monitor vital signs and observe for signs of circulatory impairment. A. ELECTROCARDIOGRAM 24 Patient Name: Mr. N Age: 46 years old Gender: Male Date/Time conducted: January 23, 2023 BEFORE: Verify the order for the ECG in the client's chart, confirm the client's Identity. Provide privacy and explain the procedure to the client. Emphasize that no electrical current will enter the body. Tell the client that the test typically takes about 5 minutes. Place the ECG machine close to the client's bed and plug the cord into the wall outlet or, battery-operated, ensure that it is functioning. Turn on the machine and input required client information. DURING: Verify the order for the ECG in the client's chart Confirm the client's Identity. Provide privacy and explain the procedure to the client. Emphasize that no electrical current will enter the body. Tell the client that the test typically takes about 5 minutes. Place the ECG machine close to the client's bed and plug the cord into the wall outlet or, battery operated, ensure that it is functioning. Turn on the machine and input required client information. AFTER: When the machine finishes recording the 12-lead ECG, remove the electrodes and clean the client's skin. After disconnecting the lead wires from the electrodes, dispose of the electrodes. Indication: Sinus Tachycardia Assist the client to a comfortable position. Remove any remaining equipment and wash your hands. Significance: An in electrocardiogram records in the heart. It's common Document your notes the test's datethe andelectrical time andsignals significant responses byathe client. and painless test used to quickly detect heart problems and monitor the heart's health. The Verify the date, time, client's name, and assigned ID number on the ECG itself. test also help diagnose and monitor conditions affecting the heart. It can be used to investigate symptoms of a possible heart problem, such as chest pain, palpitations (suddenly noticeable heartbeats), dizziness and shortness of breath. Interpretation: Alongside with presence of hemorrhage. ECG notes a sinus tachycardia is characterized by a sinus P wave at a rate of more than 100 per minute, usually followed by a QRS complex that is usually narrow (but may be wide in the presence of an underlying BBB). Associated with widened blood pressure, decrease heart rate (129 bpm) and irregular pulse rate. Nursing Considerations K. ROUTINE HEMATOLOGY 25 Patient Name: Mr. N Age: 46 years old Hgb Gender: Male RESULT 130 g/L Hct 35vol % TEST RBC Count WBC Count pH 4.60x10^12/L 5x10^9/L 7.35 DIFFERENTIAL COUNT RESULT 0.57 0.34 0.06 0.03 TEST Nuetrophils Lymphocytes Monocytes Eosinophils Basophils Band/Stabs Immature cells Platelet count NRBC 300 x10^9/L RBC INDICES 86.7 fl 29.1 pg 336 g/L 13.7 % MCV MCH MCHC RDW Date/Time conducted: January 25, 2023 REFERENCE RATE M: 135-180 g/L F: 120-160 g/L M: 40-50 vol % F: 37-47 vol % 4.5-5.9X10^12/L 5-10 x10^9/L 7.35-7.45 REFERENCE RATE 0.40-0.70 0.20-0.40 0.00-0.06 0.00-0.07 0.00-0.01 0.00-0.01 150-450 x10^9/L 82.0-95.0 fl 27.0-31.0 pg 320-360 g/L 11.6-14.6% L. SEROLOGY IMMUNOLOGY Patient Name: Mr. N Age: 46 years old Gender: Male Requesting Physician: Hospital no: 33958 ASSAY HBsAG METHOD I.C.T Date/Time conducted: January 25, 2023 Area: ER General Surgery RESULT Non-reactive M. CLINICAL HEMATOLOGY Patient Name: Mr. N Age: 46 years old TEST Gender: Male RESULT Bands/Stabs Immature Cells Platelet Count Clotting Time Bleeding Time TEST Reticulocyte Count ESR Date/Time conducted: January 25, 2023 REFERENCE RATE 0.00-0.05 150-450x10 3-6 min 1-5 min SPECIAL HEMATOLOGY RESULT Prothrombin Time Reactivated Partial Thromboplastin Time Aspartate Aminotransferase ALT TPAG 26 12.5sec 27.8 sec REFERENCE RATE 0.3-3.0% M: 0-20 mm/hr F: 0-30 mm/hr 11.7-15.3 sec 24-35 sec 45 U/L 47 U/L 8-33U/L 4-36U/L D-Dimer 0.40 ug/ml 0-0.50 ug/ml N. CLINICAL CHEMISTRY Patient Name: Mr. N Test BUN Creatinine Sodium Potassium Age: 46 years old Result 5.96 mmol/L 54.90 mmol/L 143.0 mmol/L 4.5 mmol/L Gender: Male Date conducted: January 25, 2023 Reference Value 2.5-6.1 46.0-92.0 135.0-145.0 3.5-5.5 Nursing Consideration: BEFORE: ⮚ Tell the patient that the test requires a blood sample. ⮚ Explain to the patient, who will perform the arterial puncture, when it will occur, and where the puncture site will be; radial, brachial, or femoral artery. ⮚ Inform the patient that he may not need to restrict food and fluids. ⮚ Instruct the patient to breathe normally during the test, and warn him that he may experience a brief cramping or throbbing pain at the puncture site. DURING: ● ● ● Use a heparinized blood gas syringe to draw the sample. Perform an arterial puncture or draw blood from an arterial line. Eliminate air from the sample, place it on ice immediately, and prepare to transport for analysis. AFTER: ⮚ After applying pressure to the puncture site for 3 to 5 minutes and when bleeding has stopped, tape a gauze pad firmly over it. ⮚ If the puncture site is on the arm, don’t tape the entire circumference because this may restrict circulation. ⮚ If the patient is receiving anticoagulants or has a coagulopathy, apply pressure to the puncture site longer than 5 minutes if necessary. ⮚ Monitor vital signs and observe for signs of circulatory impairment. O. ROUTINE URINALYSIS Patient Name: Mr. N Test Components Color Age: 46 years old Gender: Male Date conducted: January 25, 2023 Macroscopic Examination Result Normal Pathophysiological Basis Values Straw Straw Yellow Indication: Normal Finding Yellow to Amber in Significance: Many foods and medicines can affect the color of the to Color urine. Urine with no color may be Amber caused by long-term kidney disease or in Color uncontrolled diabetes. Red urine can be caused by blood in the urine. Implication: Patient Mr. N, urine color has a normal finding 27 Transparency / Appearance pH Protein Glucose Test Components RBC / hpf WBC / hpf Indication: Normal Finding Significance: Cloudy urine can be caused by pus, blood, sperm, bacteria, yeast, crystals, mucus, or a parasite infection, such as trichomoniasis Implication: Patient Mr. N, has a clear urine transparency which indicates a normal finding. Indication: Normal 4 4-5.8 Significance: Some foods and medicines can affect urine pH. A high pH can be caused by severe vomiting, a kidney disease, some urinary tract infections and asthma. A low pH may be caused by severe lung disease, uncontrolled diabetes, aspirin overdose, severe diarrhea, dehydration, starvation, drinking too much alcohol, or drinking antifreeze. Implication: Patient Mr. N, has a normal finfing Indication: Normal Negative Negative Significance: Protein in the urine may mean that kidney damage, an infection, cancer, systemic lupus erythematosus (SLE), or glomerulonephritis is present. Implication: Patient Mr. N found out that there is no trace of protein which indicates having no proteinuria. Indication: normal values 90 80-140 Significance: Glucose is the type of mg/dl mg/dL sugar found in blood. Normally there is very little or no glucose in urine. When the blood sugar level is very high, as in uncontrolled diabetes, the sugar spills over into the urine. Glucose can also be found in urine when the kidneys are damaged or diseased. Microscopic Examination Result Normal Pathophysiological Basis Values Indication: Below the normal value 4 4.20-6.10 Significance: Red blood cells in the urine may be caused by kidney or bladder injury, kidney stones, a urinary tract infection (UTI), inflammation of the kidneys glomerulonephritis, a kidney or bladder tumour, or systemic lupus erythematous (SLE). Implication: Patient Mr. N, has low normal value findings of which had an indication of internal bleeding Indication: Abnormal Finding 1.32 Puss cells Significance: The presence of and bacteria epithelial cells, urates and Phosphates may mean that the sample is not as should be pure as it needs to be. These cells do absent in not mean there is a medical problem, urine but the doctor may ask the patient to give another urine sample. Clear Clear 28 Implication: Patient Mr. N has a moderate to few findings. An indication of having a presence of puss cells, a sign of infection and inflammation. Nursing Considerations: BEFORE: ● Tell the patient that the test requires a urine sample ● Explain to the patient the procedure and instruct the patient to void directly into a clean, dry container. Sterile, disposable containers are recommended. Women should always have a clean-catch specimen if a microscopic examination is ordered. Feces, discharges, vaginal secretions and menstrual blood will contaminate the urine specimen. DURING: ● Collect specimens into a disposable collection apparatus consisting of a plastic bag with an adhesive backing around the opening that can be fastened to the perineal area Depending on hospital policy, the collected urine can be transferred to an appropriate specimen container ● Cover all specimens tightly, label properly and send immediately to the laboratory AFTER: ● If a urine sample is obtained from an indwelling catheter, it may be necessary to clamp the catheter for about 15-30 minutes before obtaining the sample. Clean the specimen port with antiseptic before aspirating the urine sample with a needle and a syringe. ● Observe standard precautions when handling urine specimens. ● If the specimen cannot be delivered to the laboratory or tested within an hour, it should be refrigerated or have an appropriate preservative added P. ROUTINE FECALYSIS Patient Name: Mr. N MACROSCOPIC EXAMINATION Color Age: 46 years old RESULT Brown to Greenish Brown Gender: Male NORMAL FINDINGS Brown to Greenish Brown Date conducted: January 25, 2023 PATHOPHYSIOLOGICAL BASIS Indication: NormalFinding Significance: Normal, healthy stool ranges from a shade of brown to greenish brown. This may vary of food intake and lots of colorful foods. The color is the result of what a person eat and how much bile is it in stool. Implication: Patient, has a normal finding Consistency MICROSCOPIC EXAMINATION Fat neutral fat crystals and soaps Formed Formed Colorless 18% and non-fatty acid stool Colorless 18% and non-fatty acid stool 29 Indication: Normal Finding Significance: Healthy stool is usually considered a soft, formed bowel movement. The consistency changes could be caused by an infection, nutrients not being digested due to celiac disease or a problem with the pancreas, such as pancreatic cancer or pancreatitis Implication: Patient, has a normal finding Yeast TEST RESULT Ova or Parasite Occult Blood Malarial Smear None NORMAL FINDINGS None Negative Negative Q. CT SCAN Patient Name: Mr. N Health Record: 039958 Requesting Physician: Clinical Info: Liver Blunt Trauma Findings: The lungs are clear The heart is not enlarged The aorta is unremarkable Diaphragm and sulci are intact Other chest structures are intact Impression: Unremarkable Cardio Pulmonary Findings Ms. RM, RT Rad Tech Age: 46 Gender: Male years old Access No: E22101500055 Procedure: Whole Abdomen Date conducted: January 25, 2023 Ward: Surgery Modality: DR RD, MD Radiologist R. CLINICAL CHEMISTRY Patient Name: Mr. N Requesting Physician: Dr. Yabres, MD TEST Age: 46 Gender: Date: January 252023 years old Male Hospital no: 33958 Area: Surgery Ward Aspertate Aminotransferase Alanine Aminotransferase RESULT 20U/L REFERENCE VALUE 14-0-36.0 U/L PATHOPHYSIOLOGICAL BASIS Indication: normal values 30 U/L 0.0-35.0 U/L Significance: ALT is an enzyme found in the liver that helps convert proteins into energy for the liver cells. When the liver is damaged, ALT is released into the bloodstream and levels increase. Aspartate transaminase (AST). AST is an enzyme that helps metabolize amino acids. Total Bilirubin 3.42 umol/L Direct Bilirubin 6.80 umol/L 3.42-22.23 umol/L 0.0-6.84 umol/L 30 Implication: Patient, has a normal finding Indication: normal values Bilirubin Unconjugated 18.0 umol/L 0.0-18.81 umol/L Significance: Bilirubin attached by the liver to glucuronic acid, a glucose-derived acid, is called direct, or conjugated, bilirubin. Bilirubin not attached to glucuronic acid is called indirect, or unconjugated, bilirubin. All the bilirubin in blood together is called total bilirubin. This is to examine an elevated plasma bilirubin Implication: Patient, has a normal finding Alkaline Phospate Remarks: Med Tech 104.40 U/L 38.0-126.0 U/L Time Done: Head, Anatomic & Clinical Laboratory Section Nursing Consideration BEFORE: ● Tell the patient that the test requires a blood sample. ● Explain to the patient, who will perform the arterial puncture, when it will occur, and where the puncture site will be; radial, brachial, or femoral artery. ● Inform the patient that he may not need to restrict food and fluids. ● Instruct the patient to breathe normally during the test, and warn him that he may experience a brief cramping or throbbing pain at the puncture site. DURING: ● Use a heparinized blood gas syringe to draw the sample. ● Perform an arterial puncture or draw blood from an arterial line. ● Eliminate air from the sample, place it on ice immediately, and prepare to transport for analysis. AFTER: ● After applying pressure to the puncture site for 3 to 5 minutes and when bleeding has stopped, tape a gauze pad firmly over it. ● If the puncture site is on the arm, do not tape the entire circumference because this may restrict circulation. ● If the patient is receiving anticoagulants or has a coagulopathy, apply pressure to the puncture site longer than 5 minutes if necessary. ● Monitor vital signs and observe for signs of circulatory impairment. B. ELECTROCARDIOGRAM 31 Patient Name: Mr. N Age: 46 years old Gender: Male Date/Time conducted: January 23, 2023 BEFORE: Verify the order for the ECG in the client's chart, confirm the client's Identity. Provide privacy and explain the procedure to the client. Emphasize that no electrical current will enter the body. Tell the client that the test typically takes about 5 minutes. Place the ECG machine close to the client's bed and plug the cord into the wall outlet or, battery-operated, ensure that it is functioning. Turn on the machine and input required client information. DURING: Verify the order for the ECG in the client's chart Confirm the client's Identity. Provide privacy and explain the procedure to the client. Emphasize that no electrical current will enter the body. Tell the client that the test typically takes about 5 minutes. Place the ECG machine close to the client's bed and plug the cord into the wall outlet or, battery operated, ensure that it is functioning. Turn on the machine and input required client information. AFTER: When the machine finishes recording the 12-lead ECG, remove the electrodes and clean the client's skin. After disconnecting the lead wires from the electrodes, dispose of the electrodes. Indication: Normal Assist the client to a comfortable position. Remove any remaining equipment and wash your hands. Significance: An in electrocardiogram records in the heart. It's common Document your notes the test's datethe andelectrical time andsignals significant responses byathe client. and painless test used to quickly detect heart problems and monitor the heart's health. The Verify the date, time, client's name, and assigned ID number on the ECG itself. test also help diagnose and monitor conditions affecting the heart. It can be used to investigate symptoms of a possible heart problem, such as chest pain, palpitations (suddenly noticeable heartbeats), dizziness and shortness of breath. Interpretation: Heart is beating at an even rate of 60 to 100 beats per minute Nursing Considerations S. ROUTINE HEMATOLOGY 32 Patient Name: Mr. N Age: 46 years old TEST Gender: Male Hgb RESULT 140g/L Hct 45vol % RBC Count WBC Count pH 4.5x10^12/L 6x10^9/L 7.35 DIFFERENTIAL COUNT RESULT 0.57 0.34 0.06 0.03 TEST Nuetrophils Lymphocytes Monocytes Eosinophils Basophils Band/Stabs Immature cells Platelet count NRBC 300 x10^9/L RBC INDICES 86.7 fl 29.1 pg 336 g/L 13.7 % MCV MCH MCHC RDW Date/Time conducted: January 29, 2023 REFERENCE RATE M: 135-180 g/L F: 120-160 g/L M: 40-50 vol % F: 37-47 vol % 4.5-5.9X10^12/L 5-10 x10^9/L 7.35-7.45 REFERENCE RATE 0.40-0.70 0.20-0.40 0.00-0.06 0.00-0.07 0.00-0.01 0.00-0.01 150-450 x10^9/L 82.0-95.0 fl 27.0-31.0 pg 320-360 g/L 11.6-14.6% T. SEROLOGY IMMUNOLOGY Patient Name: Mr. N Age: 46 years old Gender: Male Requesting Physician: Hospital no: 33958 ASSAY HBsAG METHOD I.C.T Date/Time conducted: January 25, 2023 Area: ER General Surgery RESULT Non-reactive U. CLINICAL HEMATOLOGY Patient Name: Mr. N Age: 46 years old TEST Gender: Male RESULT Bands/Stabs Immature Cells Platelet Count Clotting Time Bleeding Time TEST Reticulocyte Count ESR Date/Time conducted: January 29, 2023 REFERENCE RATE 0.00-0.05 150-450x10 3-6 min 1-5 min SPECIAL HEMATOLOGY RESULT Prothrombin Time Reactivated Partial Thromboplastin Time Aspartate Aminotransferase ALT D-Dimer 12.5sec 27.8 sec REFERENCE RATE 0.3-3.0% M: 0-20 mm/hr F: 0-30 mm/hr 11.7-15.3 sec 24-35 sec 30 U/L 33 U/L 0.40 ug/ml 8-33U/L 4-36U/L 0-0.50 ug/ml 33 V. CLINICAL CHEMISTRY Patient Name: Mr. N Test BUN Creatinine Sodium Potassium Age: 46 years Gender: Male old Result 5.96 mmol/L 54.90 mmol/L 143.0 mmol/L 4.5 mmol/L Nursing Consideration: Date conducted: January 25, 2023 Reference Value 2.5-6.1 46.0-92.0 135.0-145.0 3.5-5.5 BEFORE: ⮚ Tell the patient that the test requires a blood sample. ⮚ Explain to the patient, who will perform the arterial puncture, when it will occur, and where the puncture site will be; radial, brachial, or femoral artery. ⮚ Inform the patient that he may not need to restrict food and fluids. ⮚ Instruct the patient to breathe normally during the test, and warn him that he may experience a brief cramping or throbbing pain at the puncture site. DURING: ● Use a heparinized blood gas syringe to draw the sample. ● Perform an arterial puncture or draw blood from an arterial line. ● Eliminate air from the sample, place it on ice immediately, and prepare to transport for analysis. AFTER: ⮚ After applying pressure to the puncture site for 3 to 5 minutes and when bleeding has stopped, tape a gauze pad firmly over it. ⮚ If the puncture site is on the arm, don’t tape the entire circumference because this may restrict circulation. ⮚ If the patient is receiving anticoagulants or has a coagulopathy, apply pressure to the puncture site longer than 5 minutes if necessary. ⮚ Monitor vital signs and observe for signs of circulatory impairment. W. ROUTINE URINALYSIS Patient Name: Mr. N Test Components Color Transparency / Appearance Age: 46 years old Gender: Male Date conducted: January 29, 2023 Macroscopic Examination Result Normal Pathophysiological Basis Values Straw Straw Yellow Indication: Normal Finding Significance: Many foods and Yellow to to Amber in Amber in Color medicines can affect the color of the Color urine. Urine with no color may be caused by long-term kidney disease or uncontrolled diabetes. Red urine can be caused by blood in the urine. Implication: Patient Mr. N, urine color has a normal finding Indication: Normal Finding Clear Clear Significance: Cloudy urine can be caused by pus, blood, sperm, bacteria, yeast, crystals, mucus, or a parasite infection, such as trichomoniasis Implication: Patient Mr. N, has a clear urine transparency which indicates a normal finding. 34 pH Protein Glucose Test Components RBC / hpf WBC / hpf Indication: Normal Significance: Some foods and medicines can affect urine pH. A high pH can be caused by severe vomiting, a kidney disease, some urinary tract infections, and asthma. A low pH may be caused by severe lung disease, uncontrolled diabetes, aspirin overdose, severe diarrhea, dehydration, starvation, drinking too much alcohol, or drinking antifreeze. Implication: Patient Mr. N, has a normal finding Indication: Normal Negative Negative Significance: Protein in the urine may mean that kidney damage, an infection, cancer, systemic lupus erythematosus (SLE), or glomerulonephritis is present. Implication: Patient Mr. N found out that there is no trace of protein which indicates having no proteinuria. Indication: normal values 90 80-140 Significance: Glucose is the type of mg/dl mg/dL sugar found in blood. Normally there is very little or no glucose in urine. When the blood sugar level is very high, as in uncontrolled diabetes, the sugar spills over into the urine. Glucose can also be found in urine when the kidneys are damaged or diseased. Microscopic Examination Result Normal Pathophysiological Basis Values Indication: normal value 5.10 4.20-6.10 Significance: Red blood cells in the urine may be caused by kidney or bladder injury, kidney stones, a urinary tract infection (UTI), inflammation of the kidneys glomerulonephritis, a kidney or bladder tumour, or systemic lupus erythematous (SLE). Implication: Patient Mr. N, has a normal value findings Indication: normal Finding 1.32 Significance: The presence of 1-5 epithelial cells, urates and Phosphates may mean that the sample is not as pure as it needs to be. These cells do not mean there is a medical problem, but the doctor may ask the patient to give another urine sample. Implication: Patient Mr. N has a normal finding 4 4-5.8 35 X. ROUTINE FECALYSIS Patient Name: Mr. N MACROSCOPIC EXAMINATION Color Consistency MICROSCOPIC EXAMINATION Fat neutral fat crystals and soaps Age: 46 years old RESULT Brown to Greenish Brown Ova or Parasite Occult Blood Malarial Smear NORMAL FINDINGS Brown to Greenish Brown Formed Formed Colorless 18% and non-fatty acid stool Colorless 18% and non-fatty acid stool Yeast TEST Gender: Male RESULT Date conducted: January 29, 2023 PATHOPHYSIOLOGICAL BASIS Indication: Normal Finding Significance: Normal, healthy stool ranges from a shade of brown to greenish brown. This may vary of food intake and lots of colorful foods. The color is the result of what a person eat and how much bile is it in stool. Implication: Patient, has a normal finding Indication: Normal Finding Significance: Healthy stool is usually considered a soft, formed bowel movement. The consistency changes could be caused by an infection, nutrients not being digested due to celiac disease or a problem with the pancreas, such as pancreatic cancer or pancreatitis Implication: Patient, has a normal finding None NORMAL FINDINGS None Negative Negative Nursing Consideration: BEFORE: ● Assess the patient’s level of comfort. Collecting stool specimen may produce a feeling of embarrassment and discomfort to the patient. ● Encourage the patient to urinate. Allow the patient to urinate before collecting to avoid contaminating the stool with urine. ● Avoid laxatives. Advise patient that laxatives, enemas, or suppositories are avoided three days prior to collection. ● Instruct a red-meat free and high residue diet. The patient is indicated for an occult blood test, must follow a special diet that includes generous amounts of chicken, turkey, and tuna, raw and uncooked vegetables and fruits such as spinach, celery, prunes and bran containing cereal for two (2) days before the test. DURING: ● Instruct the patient to collect small amount directly into a clean, dry container. Sterile, disposable containers are recommended ● Depending on hospital policy, the collected urine can be transferred to an appropriate specimen container ● Cover all specimens tightly, label properly and send immediately to the laboratory AFTER: ● Instruct patient to do hand washing. Allow the patient to thoroughly clean his or her hands and perianal area. 36 ● Resume activities. The patient may resume his or her normal diet and medication therapy unless otherwise specified. Y. CT SCAN Patient Name: Mr. N Age: 46 Gender: Male years old Access No: E22101500055 Procedure: Whole Abdomen Health Record: 039958 Requesting Physician: Clinical Info: No more Liver Blunt Trauma Findings: The lungs are clear The heart is not enlarged The aorta is unremarkable Diaphragm and sulci are intact Other chest structures are intact Impression: Unremarkable Cardio Pulmonary Findings Ms. RM, RT RD, MD Rad Tech Radiologist Date conducted: January 29, 2023 Ward: Surgery Modality: DR Nursing Consideration: BEFORE: Explain to the patient the purpose of the test. Tell him who will perform the test and where it will take place. Inform the patient that he will need to lie flat on a narrow bed, which slides into a large cylinder that houses the MRI magnets. Explain to the patient that MRI is painless and involves no exposure to radiation from the scanner. A radioactive contrast dye may be used, depending on the tissue being studied. Advise the patient that he will have to remain still for the entire procedure. Explain to the patient who is claustrophobic or anxious about the test’s duration that he will receive a mild sedative to reduce his anxiety or that he may need to be scanned in an open MRI scanner, which may take longer but is less confining. Tell him that he will be able to communicate with the technician at all times and that the procedure will be stopped if he feels claustrophobic. If contrast media will be used, obtain a history of allergies or hypersensitivity to these agents. Mark any sensitivities on the chart and notify the practitioner. Instruct the patient to remove all metallic objects, including jewelry, hairpins, and watches. Ask the patient if he has any implanted metal devices or prostheses, such as vascular clips, shrapnel, pacemakers, joint implants, filters, and intrauterine devices. If so, the test may not be able to be performed. Make sure that the patient or a responsible family member has signed an informed consent form. Administer the prescribed sedative if ordered. At the scanner room door, recheck the patient one last time for metal objects. DURING: Remind the patient to remain still throughout the procedure. Assess how the patient responds to the enclosed environment. Provide reassurance if necessary. Monitor the cardiac function for signs of ischemia (chest pressure, shortness of breath, or changes in hemodynamic status). AFTER: The nurse should be aware of these post-procedure nursing interventions after magnetic resonance imaging: Tell the patient that he may resume his usual activities as ordered. 37 If the test took a long time and the patient was lying flat for an extended period, observe him for orthostatic hypotension. Provide comfort measures and pain medication as needed and ordered because of prolonged positioning the scanner. Monitor the patient for the adverse reaction to the contrast medium (flushing, nausea, urticaria, and sneezing). Z. CLINICAL CHEMISTRY Patient Name: Mr. N Requesting Physician: Dr. Yabres, MD TEST Aspertate Aminotransferase Alanine Aminotransferase Total Bilirubin Direct Bilirubin Bilirubin Unconjugated Age: 46 Gender: Date: January 29, 2023 years old Male Area: Surgery Ward Hospital no: 33958 RESULT 20U/L REFERENCE VALUE 14-0-36.0 U/L PATHOPHYSIOLOGICAL BASIS Indication: normal values 30 U/L 0.0-35.0 U/L Significance: ALT is an enzyme found in the liver that helps convert proteins into energy for the liver cells. When the liver is damaged, ALT is released into the bloodstream and levels increase. Aspartate transaminase (AST). AST is an enzyme that helps metabolize amino acids. 3.42 umol/L 6.80 umol/L 18.0 umol/L Implication: Patient, has a normal finding 3.42-22.23 umol/L Indication: normal values 0.0-6.84 umol/L 0.0-18.81 umol/L Significance: Bilirubin attached by the liver to glucuronic acid, a glucosederived acid, is called direct, or conjugated, bilirubin. Bilirubin not attached to glucuronic acid is called indirect, or unconjugated, bilirubin. All the bilirubin in blood together is called total bilirubin. This is to examine an elevated plasma bilirubin Implication: Patient, has a normal finding Alkaline Phospate Remarks: Med Tech 104.40 U/L Time Done: 38.0-126.0 U/L Head, Anatomic & Clinical Laboratory Section 38 Nursing Consideration BEFORE: ⮚ Tell the patient that the test requires a blood sample. ⮚ Explain to the patient, who will perform the arterial puncture, when it will occur, and where the puncture site will be; radial, brachial, or femoral artery. ⮚ Inform the patient that he may not need to restrict food and fluids. ⮚ Instruct the patient to breathe normally during the test, and warn him that he may experience a brief cramping or throbbing pain at the puncture site. DURING: ● Use a heparinized blood gas syringe to draw the sample. ● Perform an arterial puncture or draw blood from an arterial line. ● Eliminate air from the sample, place it on ice immediately, and prepare to transport for analysis. AFTER: ⮚ After applying pressure to the puncture site for 3 to 5 minutes and when bleeding has stopped, tape a gauze pad firmly over it. ⮚ If the puncture site is on the arm, don’t tape the entire circumference because this may restrict circulation. ⮚ If the patient is receiving anticoagulants or has a coagulopathy, apply pressure to the puncture site longer than 5 minutes if necessary. ⮚ Monitor vital signs and observe for signs of circulatory impairment. VI. PERSON ASSESSMENT 39 Demographic and Biological Data Mr. N 46 years old September 23, 1976 Patient initials Age Date of birth Place of birth Sex Bayombong, Nueva Vizcaya Male Address Magsaysay, Bayombong, Nueva Vizcaya Civil Status Married Chief complaints NOI: Motor Accident TOI: 9:30 PM POI: Busilac, Bayombong, Nueva Vizcaya DOI: July 23, 2023 Admitting Diagnosis Final Diagnosis Admitting Physician Date of Admission Date of Discharge Current Health Problems Motor Vehicle Accident S/P Exploratory laparotomy, Evacuation of peritoneum, Perihepatic Packing, Central Venous Catheter insertion via right femoral vein Dr. A January 23, 2023 January 29, 2023 HEALTH HISTORY ⮚ Mr. N is a 46-year-old male who rushed into Region II Trauma Medical Center, Bayombong, Nueva Vizcaya, via ambulance car due to a motor vehicle accident on January 23, 2023, at around 10:00 in the evening. Past Health Problems Surgical History ⮚ Mr. N did not undergo any surgical procedures. Accidents ⮚ According to the patient, he was also hospitalized in his early twenties because of a minor car accident. Family Risk Factors Medications ⮚ Hypertension ⮚ The patient has no maintenance drugs taking. According to the patient, he has a history of a motor vehicle accident when he was in his early twenties, which he describes as a minor accident when he rides a tricycle, in which he got a minor abrasion on his legs and arms. PSYCHOSOCIAL Significant Others Wife The wife, Mrs. M, accompanied her husband to region 2 Trauma Medical Center all throughout the hospitalization. Mrs. M 40 Structure of Family Nuclear Coping Mechanism He received support from his wife and children. Mr. N has a traditional family structure which composed of husband, wife, and children. He is expressing how he feels to his wife and spending time with his children. Religion Primary language Primary source of healthcare Financial Resources Related to Health Care Occupation Educational Attainment General Appearance Level of Consciousness Coping strategies is used to overcome stressful events that people face in every day because it helps to relieve stress and regain control over that stressful event. Roman Catholic Ilocano and Tagalog Region II Trauma Medical Center (R2TMC) PhilHealth & SSS Foreman College graduate PRE-ASSESSMENT POST-ASSESSMENT PATHOPHYSIOLOGI January 23, 2023 January 29, 2023 CAL BASIS 10:30 PM 8:00 AM Patient is lying at the bed Patient is wearing a sando The abrasions and wearing a hospital gown. lacerations were and short pants. He is not well groomed caused by the Patient is awake and and has multiple vehicular crash he coherent. abrasions and a large experienced. bruise on his stomach was noted. Eye opening: 3 (to verbal Eye opening: stimuli, command, and 4(spontaneously) speech) Verbal Response: Verbal Response: 4 5(Confused) (Confused) Motor Response: 6(Obeys Motor Response: 5 command) (moves to localized pain) GCS-15 GCS-12 Eye opening: 4- spontaneously 3-to speech 2- to pain 1-no response Verbal response 5-oriented 4-confused 3-inappropriate words 2-incomprehensible sound 1-no response Motor response 6-obeys command 5-moves to localized pain 4-flex to withdraw from pain 3-abnormal flexion 2-abnormal extension 1-no response 41 Affect Orientation The patient has an The patient has an appropriate affect with appropriate affect. The client his current condition. shows appropriate The patient shows worry facial expressions in about his current relation to emotions. condition. The patient has difficulty Mr. N is aware of the date, concentrating and time and who was with delayed response on the him. questions asked by the nurse. Questions Time: Question: Alam nyo po ba kung anong petsa po ngayon? Answer: January 23, 2023 (delayed response) Place: Question: Alam niyo po ba kung saan kayo ngayon? Answer: Oo nasa hospital ako ngayon Date: Question: Sir, alam nyo po ba kung anong araw na po ngayon? Answer: Opo, Linngo na po ngayon. January 29, 2023 po Time: Question: Sir, alam nyo po ba king anong oras na ngayon? Answer: (looks to the wall clock) 8:00 na po ng umaga Person: Question: Kilala nyo po ba kung sino kasama nyo ngayon sir? Answer: Opo, yung Mrs. ko po (looks to his wife) The client’s memory is The client’s memory is intact but has a delayed intact. response Memory • • Immediate memory: Patient instructed to repeat the numbers “1,3,5,8,15” ⮚ Question: Sir pakiulit po yung sasabihin ko “1,3,5,8,15” ⮚ Answer: Patient repeat number “1.3,58,15” Recent memory: Patient recent memory was intact, Mr. N remembered • • Immediate memory: Patient instructed to repeat the numbers “1,3,5,8,15” ⮚ Question: Sir pakiulit po yung sasabihin ko “1,3,5,8,15” ⮚ Answer: Patient repeat number “1.3,58,15” Recent memory: Patient recent memory was intact, Mr. N remembered what he was doing before the accident. 42 It is natural for the patient to exhibit restrictive emotion as a result of worry and fatigue associated with his current condition, as evidenced by his facial expression and body language/movement . Checking orientation of the client help the nurses to evaluate mental status and help to diagnose other condition caused by the incident. what he was doing before the accident. ⮚ Question: Sir naalala nyo po ba yung ginagawa nyo bago po kayo naaksidente?” ⮚ Answer: “nagsalosalo po kami ng • mga katrabaho ko” • Remote memory: Patient remote memory was intact because he remembers the date of his birthday. ⮚ Question: Sir naalala nyo po ba yung ginagawa nyo bago po kayo naaksidente” ⮚ Answer: “nagsalosalo po kami ng mga katrabaho ko” Remote memory: Patient remote memory was intact because he remembers the date of his birthday. ⮚ Question: Kaylan po birthday nyo sir? ⮚ Answer: September 23, 1976 ⮚ Question: Kaylan po birthday nyo sir? ⮚ Answer: September 23, 1976 Speech Client speaks and responds with a clear and modulated voice with normal pace. Nonverbal behavior The patient was looking on the ceiling, facial grimace was noted upon assessment. Client speaks and responds with a clear and modulated voice with normal pace. He is smiling and he keeps Due to the pain on his eye contact. Patient was abdomen, facial nodding when he agrees to grimace was noted the questions. upon assessment. ELIMINATION PREASSESSMENT January 23, 2023 10:30 PM POSTASSESSMENT January 29, 2021 8:00 AM STOOL Frequency Patient usually defecate once a day in the morning Once a day Pattern Every morning around 6:00 AM – 7:00 AM Early in the morning Consistency and shape Soft to Hard and well formed Soft and well formed Presence of unusual odor None None 43 PATHOPHYSIOLOGICAL BASIS Color Yellow to brown Yellow to brown 30 ml URINE 1200 ml 15-30 minutes every after drinking water Patient usually urinate every 4 hours. None None Pale yellow Pale yellow With difficulty or with pain upon urination No difficulty and no pain upon urination. No difficulty and no pain upon urination. Toileting Ability Patient can sit/stand upright on toilet to urinate and defecate and can undress his self without any assistance. Urinates and defecates in the toilet with minimal assistance upon walking ahead to the toilet. Due to post-surgical incision and abrasion, patient needs minimal assistance. Abdomen Patient’s abdomen was swollen and has a large, bluishpurplish bruise that is 5 inches in diameter Patient abdomen has a post-surgical vertical midline incision. Due to the trauma from the accident, his abdomen got slammed into the tree resulting in swollen abdomen with a presence of large bruise. Amount Frequency Presence of unusual odor Color REST AND ACTIVITY Current Activity Level ADL’s The client can: • Groom Himself • Feed Himself • Move PREASSESSMENT January 23, 2023 10:30 PM Mr. N was lying in bed, can perform hand gestures but cannot tolerate to reposition his self. POSTASSESSMENT January 29, 2022 8:00 AM The patient can reposition his self in bed with minimal assistance. The patient cannot groom himself independently. The patient spends most of his time resting in his bed. Mr. N was not able to eat as he was undergone for emergency E-lap. Mr. N needs assistance when wearing his clothes 44 PATHOPHYSIOLOGICAL BASIS Limited movement due to the pain on pre assessment and post-surgical incision. • Communicat e The patient cannot walk due to pain from his abdomen. He can communicate effectively but not instantly. Sleep Pattern Body Frame Posture Gait Coordinatio n Balance Motor Function Muscle Strength and perform his personal hygiene. The patient need assistance when moving in his bed. The patient speaks with a modulated voice with a normal pace. Duration: 6-7 hours Duration: 6-7 hours. from 11 pm to 5 am. Patient has disturbed No sleep during the sleeping pattern day. because of the pain from his incision sight. Endomorph The patient’s posture was not assessed because he was brought in the ER lying in a stretcher Endomorph Endomorphs are rounded, with lots of muscle and body fat, a stockier structure, and a slower metabolism. Patient can finally sit but slouchy. The patient walks The patient’s gait was slowly with minimal not assessed support from his because he was wife. Arm swing brought in the ER through foot and lying in a stretcher move forwards at the same time. Coordinated using nose to finger test with slow response. N/A Coordinated using nose to finger test. Patient needs minimal assistance when walking and sitting. Gross: Mr. N can flex Gross: Mr. N can upper extremities and flex upper lower extremities. extremities and lower Can bend his head at extremities. Can all sides. bend his head at all sides. Fine: Mr. N can hold light material like a Fine: Mr. N can hold ball pen and can light material like a write ball pen and can write Patient has no Patient has no involuntary involuntary movements like movements like twitching and spasms twitching and or a y uncoordinated spasms or a y movement. 45 0- Complete absence of muscle movement 1- No movement, contraction of the muscle is palpable 2- Full muscle movement against gravity with support uncoordinated movement. Muscle strength grade - 4 Muscle strength grade - 4 Mobility/ use Patient does not use of assistive assistive device for devices mobility. Patient assisted with his wife. 3- Full range of motion against gravity 4- Full range of motion against gravity and minimal resistance 5- Full range of motion against gravity and full resistance Patient used wheelchair upon discharge from the ward to the car. SAFE ENVIRONMENT Allergies Eyes/ Vision Pre-Assessment Post- Assessment (January 23, 2023) (January 29, 2023) No allergies to food, drug, and environment. No allergies to food, drug, and environment. PATHOPHYSIOLOGICAL BASIS Pupils are equal and Pupils are equal and round, reactive to round, reactive to light, and light, and accommodate. He is accommodate. He is not using eyeglasses. not using eyeglasses. Hearing He is not using hearing aids. He is not using hearing aids Skin Integrity Skin is brown in color and feels cold and clammy. Skin is brown in color and feels warm and dry. • Abrasions that are superficial in depth and with a size of: Abrasions that are superficial in depth and with a size of: >Left cheek: 2cm >Left cheek: 2cm >Right hand: 2cm >Right hand: 2cm >Right arm: 3.5cm >Right arm: 3.5cm >Left arm: 3cm >Left arm: 3cm >Right upper leg: 3.5cm >Right upper leg: 3.5cm 46 The patient sustained multiple abrasions from getting involved in a motor vehicular accident >Left lower leg: 3cm >Left lower leg: 3cm >5” surgical vertical midline incision Breast No masses and tenderness upon No masses and tenderness upon palpation palpation Nose The nasal septum is in the midline, mucosa is moist The nasal septum is in the midline, mucosa is moist Neck Neck muscles are equal in size. No tenderness and masses upon palpation. Neck muscles are equal in size. No tenderness and masses upon palpation. Dry mucous membranes Mucous membranes are moist and intact. The patient was having active bleeding leading to decreased blood volume, thereby causing a decrease in blood flow to peripheral tissues 35.8°C 36.7°C The temperature was decreased due to energy deficit Mucous Membrane Temperature 47 OXYGENATION Activity Intolerance Airway Clearance Respiratory Rate Pre-Assessment Post- Assessment (January 23, 2023) (January 29, 2023) The patient cannot perform activities independently due to pain and weakness The patient’s movement is minimal due to the surgery. Clear and open airways. No blockages or obstruction noted Clear and open airways. No blockages or obstruction noted 38 cpm 20 cpm 48 PATHOPHYSIOLOGICAL BASIS Movement is minimal due to the trauma The patient is tachypneic due to poor perfusion of tissues from loss of too much blood Capillary Refill Patient’s capillary refill takes more than 3 seconds. Patient’s capillary refill is normal, as it goes back to its pinkish color within 2 seconds. Oxygen Saturation 90% 97% Pulse Rate 129 bpm 86 bpm Blood Pressure 60/40 mmHg 110/80 m Low oxygen saturation is due to poor perfusion of tissues attributed to the hypovolemic shock The patient is experiencing tachycardia due to decreased blood volume from massive bleeding A drop in blood pressure is a result of the patient’s decreased cardiac output NUTRITION Pre-Assessment (January 23, 2023) Diet Restrictions Post- Assessment (January 29, 2023) PATHOPHYSIOLOGICAL BASIS NPO DAT Fluid Intake Not assessed 500ml of water Height and Weight Weight: 85 kg Weight: 85 kg Height: 5’8” BMI: 24.8 kg/m2 Height: 5’8” The patient was placed on NPO for emergency surgery BMI: 24.8 kg/m2 Tissue Turgor Recoil of skin takes more than 3 seconds to return to its original state An immediate recoil of skin that goes back in less than 2 49 The blood flow to peripheral tissue is reduced causing poor skin turgor Ability - Che w food - Swall ow - Feed self Not assessed Patient is able to chew food, swallow, and feed himself 50 The patient was placed on NPO for emergency surgery VII. Name of Medication Generic name: Sodium bicarbonate Brand name: Date given: January 23, 2023 Date Discontinued: Classification Doctor’s Order Alkanizing Agents Time: 5:35AM Route: IV Frequency: Q4 Form: 2-5 mEq/kg IV infusion over 4-8 hr DRUG STUDY Mechanism of Action Bicarbonate reacts with H+ ions to form water & carbon dioxide. It acts as a buffer against acidosis by raising blood pH Side effects Frequent urge to urinate headache (continuing) loss of appetite (continuing) mood or mental changes muscle pain or twitching nausea or vomiting nervousness or Indication: restlessness slow breathing Treatment of metabolic acidosis, swelling of feet or lower which may occur in severe renal legs disease, and severe primary lactic unpleasant taste acidosis. unusual tiredness or weakness January 29, 2023 Adverse effects Aggravated CHF Cerebral hemorrhage Edema Hypernatremia Hypocalcemia Hypokalemia Tetany Metabolic alkalosis Belching Gastric distension Pulmonary edema Hypernatremia Hyperosmolality Intracranial acidosis Milk-alkali syndrome Nursing consideration 1. 2. 3. Contraindication: Hypersensitivity Injection ● Chloride loss due to vomiting or from continuous gastrointestinal suction ● Currently treated with diuretics 4. 5. Assess the client’s fluid balance throughout the therapy. This assessment includes intake and output, daily weight, edema and lung sounds. Symptoms of fluid overload should be reported such as hypertension, edema, difficulty breathing or dyspnea, rales or crackles and frothy sputum. Sigs of acidosis should be assessed such as disorientation, headache, weakness, dyspnea and hyperventilation. Assess for alkalosis by monitoring the client for confusion, irritability, paresthesia, tetany and altered breathing pattern. Hypernatremia clinical manifestations should be assessed and monitored which includes: edema, weight gain, hypertension, tachycardia, fever, flushed skin and mental irritability. 6. Hypokalemia should also be assessed by monitoring signs and symptoms such as: weakness, fatigue, U wave on ECG, arrhythmias, polyuria and polydipsia. 7. IV sites should be observed closely. Extravasation should be avoided as tissue irritation or cellulitis may occur when taking sodium bicarbonate. 8. If infiltration occurs, the physician should be notified immediately. Confer with the doctor or other health care staff regarding warm compresses and infiltration site with lidocaine or hyaluronidase. 52 9. Monitor the client’s serum calcium, sodium, potassium, bicarbonate concentrations, serum osmolarity, acid-base balance and renal function before and throughout the therapy. 10. Tablets must be taken with a full glass of water. 11. For clients taking the medication as a treatment for peptic ulcers it may be administered 1 and 3 hours after meals and at bedtime. Name of Medication Generic name: Epinephrine Brand name: Adrenalin Classification Doctor’s Order alpha- and betaadrenergic agonists Time: Route: IV Frequency: PRN Mechanism of Action Side effects Adverse effects Epinephrine acts on alpha and betaadrenergic receptors. Epinephrine acts on alpha and beta-receptors and is the strongest alpha-receptor activator. Through its action on alpha-adrenergic receptors, epinephrine minimizes the vasodilation and increased the vascular permeability that occurs Fast/pounding heartbeat, nervousness, sweating, nausea, vomiting, trouble breathing, headache, dizziness, anxiety, shakiness, or pale skin Tachycardia, hypertension, headache, anxiety, apprehension, palpitations, diaphoresis, nausea, vomiting, weakness, tremors. 53 Nursing consideration ▪ Monitor BP, pulse, respirations, and urinary output and observe patient closely following IV administration. Epinephrine may widen pulse pressure. If Date given: January 23, 2023 Date Discontinued: January 29, 2023 Form: 0.3 milligram (mg) during anaphylaxis, which can cause the loss of intravascular fluid volume as well as hypotension. Epinephrine relaxes the smooth muscle of the bronchi and iris and is a histamine antagonist, rendering it useful in treating the manifestations of allergic reactions and associated conditions. This drug also produces an increase in blood sugar and increases glycogenosis in the liver. Through its action on beta-adrenergic receptors, epinephrine leads to bronchial smooth muscle relaxation that helps to relieve bronchospasm, wheezing, and dyspnea that may occur during anaphylaxis ▪ ▪ ▪ Indication: Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase blood pressure in adult patients with hypotension. ▪ ▪ Contraindication: There are no absolute contraindications against using epinephrine. Some relative contraindications include hypersensitivity to sympathomimetic drugs, closedangle glaucoma, and anesthesia with 54 ▪ disturbances in cardiac rhythm occur, withhold epinephrine and notify physician immediately. Keep physician informed of any changes in intakeoutput ratio. Use cardiac monitor with patients receiving epinephrine IV. Have full crash cart immediately available. Check BP repeatedly when epinephrine is administered IV during first 5 min, then q3–5min until stabilized. Advise patient to report to physician if symptoms are not relieved in 20 min or if they become worse following inhalation. Advise patient to report bronchial irritation, nervousness, or sleeplessness. Dosage should be reduced. Monitor blood glucose & HbA1c for halothane. Another unique contraindication to be aware of is catecholaminergic polymorphic ventricular tachycardia. Name of Medication Generic name: Norepinephrine Brand name: Levophed Date given: Jnuary23, 2023 Date Discontinued: January 29, 2023 Classification Doctor’s Order sympathomimetic Time: Route: IV Frequency: PRN Form: Mechanism of Action Side effects Norepinephrine functions as a peripheral vasoconstrictor by acting on alphaadrenergic receptors. It is also an inotropic stimulator of the heart and dilator of coronary arteries because of its activity at the betaadrenergic receptors. Indication: 8-12 mcg/minute intravenous (IV) infusion; titrate to effect loss of glycemic control if diabetic. Norepinephrine injection is used to raise blood pressure in patients with severe, acute hypotension (short-term low blood pressure) Contraindication: Generally, norepinephrine should be avoided in patients with mesenteric or 55 Adverse effects ● ● Blurred vision ● chest pain or discomfort ● headache ● ● lightheadedness, dizziness, or fainting ● ● nervousness ● pounding in the ears ● slow, fast, or irregular heartbeat ● unusual tiredness or weakness ● Allergic reactions like skin rash, itching or hives, swelling of your face, lips or tongue. Difficulty breathing, wheezing. Irregular heartbeats, palpitations or chest pain. Pain, redness or irritation at site where injected. Nursing consideration ▪ ▪ Monitor constantly while patient is receiving norepinephrine. Take baseline BP and pulse before start of therapy, then q2min from initiation of drug until stabilization occurs at desired level, then every 5 min during drug administration. Adjust flow rate to maintain BP at low normal (usually 80–100 mm Hg systolic) in normotensive patients. In previously hypertensive patients, systolic is generally maintained no higher peripheral vascular thrombosis as the subsequent vasoconstriction will increase the area of ischemia and infarction. ▪ ▪ ▪ ▪ 56 than 40 mm Hg below preexisting systolic level. Observe carefully and record mental status (index of cerebral circulation), skin temperature of extremities, and color (especially of earlobes, lips, nail beds) in addition to vital signs. Monitor I&O. Urinary retention and kidney shutdown are possibilities, especially in hypovolemic patients. Urinary output is a sensitive indicator of the degree of renal perfusion. Report decrease in urinary output or change in I&O ratio. Be alert to patient’s complaints of headache, vomiting, palpitation, arrhythmias, chest pain, photophobia, and blurred vision as possible symptoms of over dosage. Reflex bradycardia may occur as a result of rise in BP. Continue to monitor vital signs and observe patient closely after cessation of therapy for clinical sign of circulatory inadequacy. Name of Medication Generic name: Dopamine Brand name: Intropine Date given: Janyary 23, 2023 Date Discontinued: January 29, 2023 Classification Doctor’s Order Adrenergic Time: Route: IV Frequency: PRN Form: 5 mcg/kg per minute (5 mcg/Kg/min) Mechanism of Action Dopamine is a precursor ● to norepinephrine in ● noradrenergic nerves and ● is also a neurotransmitter ● in certain areas of the ● central nervous system.● Dopamine produces ● positive chronotropic and ● inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on betaadrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings. In the brain, dopamine acts as an agonist to the five dopamine receptor subtypes (D1, D2, D3, D4, D5). Side effects Irregular heartbeats Nausea Vomiting Anxiety Headache Chills Goosebumps Shortness of breath Adverse effects ● ● ● ● ● ● ● ● ● ● ● 57 lightheadedness, chest pain, fast, slow, or pounding heartbeats, shortness of breath, cold feeling, numbness, blue-colored appearance in your hands or feet, and darkening or skin changes in your hands or feet Heart arrhythmias that can be lifethreatening Kidney damage Gangrene of digits at the higher doses. Nursing consideration Monitor hemodynamics closely: BP, HR, EKG, CVP, and PAOP if available • Obtain parameters for hemodynamic values • Titrate to obtain appropriate BP (more potent vasoconstrictors may be required) • Irritation may occur at IV site • Beta blockers may counteract therapeutic effects Indication: Dopamine is a peripheral vaso stimulant used to treat low blood pressure, low heart rate, and cardiac arrest. Contraindication: Patients with pheochromocytoma or uncorrected tachyarrhythmias including ventricular fibrillation and ventricular tachycardia. Reduce the dopamine dose if an increased number of ectopic beats is observed. Correct hypovolemia before dopamine administration. Name of Medication Classification Doctor’s Order Mechanism of Action Side effects 58 Adverse effects Nursing consideration Generic name: Dobutamine Brand name: Inotrex Inotropic Agent Time: Route: IV Frequency: Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output. Indication: Date given: January 23, 2023 Date Discontinued: January 29, 2023 PRN Form: 0.5 to 1.0 mcg/kg/min ● ● ● ● ● low blood pressure, chest pain (angina), fast or slow heartbeat, shortness of breath, and trouble breathing Dobutamine's inotropic effect increases contractility, leading to decreased end-systolic volume and, therefore, increased stroke volume. The increase in stroke volume leads to an augmentation of the cardiac output of the heart. ● ● ● ● ● ● ● ● ● increased heart rate and increased blood pressure, ventricular ectopic activity, nervousness, headache, nausea, vomiting, palpitations, low platelet counts (thrombocytopenia), swelling at the injection site. ● ● ● ● ● ● Contraindication: The medication is contraindicated in patients with acute myocardial infarction, unstable angina, left main stem disease, severe hypertension, arrhythmias, acute myocarditis or pericarditis, hypokalemia and idiopathic 59 Observe IV site closely and avoid extravasation. Dobutamine can cause inflammatory response and tissue ischaemia. Monitor for adverse reactions. Continuous blood pressure monitoring. Continuous cardiorespiratory monitoring. Document vital signs hourly and PRN. Monitor fluid balance. hypertrophic sub-aortic stenosis. Name of Medication Generic name: Dopamine Brand name: Classificatio Doctor’s Order n Adrenergic Time: Route: IV Frequency: Date given: Date Discontinue d: Form: 5 mcg/kg per minute (5 mcg/Kg/min) Mechanism of Action Dopamine is a precursor ● to norepinephrine in ● noradrenergic nerves ● and is also a ● neurotransmitter in ● certain areas of the ● central nervous system.● Dopamine produces ● positive chronotropic and inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on betaadrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings. In the brain, dopamine acts as an agonist to the five dopamine receptor Side effects Irregular heartbeats Nausea Vomiting Anxiety Headache Chills Goosebumps Shortness of breath Adverse effects ● ● ● ● ● ● ● ● ● ● ● 60 lightheadedness, chest pain, fast, slow, or pounding heartbeats, shortness of breath, cold feeling, numbness, blue-colored appearance in your hands or feet, and darkening or skin changes in your hands or feet Heart arrhythmias that can be life-threatening Kidney damage Gangrene of digits at the higher doses. Nursing consideration Monitor hemodynamics closely: BP, HR, EKG, CVP, and PAOP if available • Obtain parameters for hemodynamic values • Titrate to obtain appropriate BP (more potent vasoconstrictors may be required) • Irritation may occur at IV site • Beta blockers may counteract therapeutic effects subtypes (D1, D2, D3, D4, D5). Indication: Dopamine is a peripheral vaso stimulant used to treat low blood pressure, low heart rate, and cardiac arrest. Contraindication: Patients with pheochromocytoma or uncorrected tachyarrhythmias including ventricular fibrillation and ventricular tachycardia. Reduce the dopamine dose if an increased number of ectopic beats is observed. Correct hypovolemia before dopamine administration. 61 Name of Medication Generic name: Acetaminoph en Brand name: tylenol Date given: January 23, 2023 Date Discontinue d: January 29, 2023 Classificatio Doctor’s Order n Analgesics Time: 7:00AM Route: IV Frequency: Q4 Form: 500mg/50ml Mechanism of Action According to its FDA labeling, acetaminophen's exact mechanism of action has not been fully established despite this, it is often categorized alongside NSAIDs (nonsteroidal anti-inflammatory drugs) due to its ability to inhibit the cyclooxygenase (COX) pathways. It is thought to exert central actions, which ultimately lead to the alleviation of pain symptoms. Indication: Side effects ● red, peeling or blistering skin ● rash ● hives ● itching ● swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs ● hoarseness ● difficulty breathing or swallowing Adverse effects ● Skin rash, hypersensitivity reactions ● Nephrotoxicity (elevations in BUN, creatinine) ● Hematological: anemia, leukopenia, neutropenia, pancytopenia ● Metabolic and electrolyte ● o Decreased serum bicarbonate o Decreased concentrations of sodium and calcium o Hyperammone mia o Hyperchloremia o Hyperuricemia o Increased serum glucose This drug is used to treat mild to moderate pain. Contraindication: Hypersensitivity to acetaminophen, severe hepatic impairment, or severe active hepatic disease. 62 Nursing consideration 1. Assess for an allergy to acetaminophen. 2. Assess for pain by having the patient rate on a scale of 1-10, and describe characteristics, duration, and frequency. Assess for chronic conditions that warrant the use of acetaminophen such as arthritis. 3. If given as an antipyretic, assess temperature. 4. Assess for pregnancy or lactation. Acetaminophen is a category B risk meaning the risk of fetal harm is possible but unlikely. Administration is safe under the prescription and supervision of a healthcare provider. 5. Assess for acetaminophen toxicity: nausea, vomiting, abdominal pain, elevated bilirubin and liver enzymes. o Name of Medication Generic name: Benzylpenicillin Brand name: Bicillin Date given: January 24, 2023 Date Discontinued: Classification Doctor’s Order Beta-lactam Antibiotic Time: 6:00AM Route: IV Frequency: Q6 Form: 125mg Mechanism of Action By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, penicillin G inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that penicillin G interferes with an autolysin inhibitor. Side effects ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● nausea, vomiting, diarrhea, rash, abdominal pain, urticaria. muscle spasms, fever, chills, muscle pain, headache, tachycardia, flushing, tachypnea, hypotension. 63 Increased bilirubin and alkaline phosphatase Adverse effects ● Hypersensitivity Reactions: The commonly encountered adverse drug reaction with penicillin is hypersensitivity of immediate onset or delayed onset. o Immediate onset: This kind of reaction occurs within 20 minutes postadministration. It is characterized by urticaria, pruritis, edema, laryngospasm, Nursing consideration ● ● Watch for seizures; notify physician immediately if patient develops or increases seizure activity. Monitor signs of allergic reactions and anaphylaxis, including pulmonary symptoms (tightness in the throat and chest, wheezing, cough dyspnea) or skin reactions (rash, prurits, urticaria). Notify physician or nursing staff immediately if these reactions occur. January 29, 2023 Indication: bronchospasm, hypotension, vascular collapse, and death. Treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia. o Contraindication: ● A previous history of severe allergic reactions or penicillin and its derivatives. Penicillin is also contraindicated in patients who have had Stevens-Johnson syndrome after administering penicillin or a penicillin derivative. ● 64 Delayed onset: This reaction occurs within 1 to 2 weeks of treatment. It is rare and is characterized by fever, malaise, urticaria, myalgia, arthralgia, abdominal pain, and skin rashes. Gastrointestinal System: GI symptoms were the most common and were reported in over 1% of patients, including nausea, vomiting, stomatitis, which are commonly observed with oral administration. Pseudomembranous colitis is also observed during or after the treatment. Hematologic Reactions: If the dose is exceeded 10 million units/day and if a patient has received a higher dose previously, then those patients can precipitate Coombs positive hemolytic anemia and neutropenia, ● ● ● Assess muscle aches and joint pain (arthralgia) that may be caused by serum sickness. Notify physician if these symptoms seem to be drug related rather than caused by musculoskeletal injury or if muscle and joint pain are accompanied by allergy-like reactions (fever, rashes, etc.) Monitor signs of eosinophilia (fatigue, weakness, myalgia) or leukopenia (fever, sore throat, signs of infection); report these signs to the physician. Monitor injection site for pain, swelling, and irritation. Report prolonged or excessive injection site reactions to the physician. which is resolved when therapy is stopped. Name of Medication Generic name: Tranexamic Acid Brand name: Hemostan Date given: January 23, 2023 Classification Doctor’s Order Anti-fibrinolytic, Time: antihemorrhagic Route: IV Frequency: PRN Form: Mechanism of Action Tranexamic acid is an ● antifibrinolytic agent that inhibits the breakdown of fibrin clots. It blocks the● lysine binding sites of ● plasminogen and impairs ● the endogenous fibrinolytic process, thus preserving and stabilising the fibrin● matrix structure. ● Additionally, it reduces inflammation associated 65 ● Metabolic Reactions: The salt form of penicillin G may cause electrolyte imbalances, i.e., hyperkalemia when given IV in a large dose. ● Nervous System: Neurological manifestations include hyperreflexia, myoclonic twitches, seizures, and coma after IV doses and are more likely in patients with impaired renal function. Side effects Abdominal or stomach pain, discomfort, or tenderness. chills or fever. difficulty with moving. headache, severe and throbbing. joint or back pain. muscle aching or cramping. Adverse effects Nursing consideration Significant: Visual defects (e.g. changes in color vision, visual loss), retinal venous and arterial occlusions, ligneous conjunctivitis; convulsions (particularly with high doses of IV inj), severe hypersensitivity reactions (e.g. 1. Unusual change in bleeding pattern should be immediately reported to the physician. 2. For women who are taking Tranexamic acid to control heavy bleeding, the medication should only be taken during the menstrual period. Date Discontinued: January 29, 2023 50mg/min with hereditary ● angioedema by inhibiting the proteolytic activity of plasmin which decreases the activation of complement and consumption of C1 esterase inhibitor (C1INH). Indication: Tranexamic acid (sometimes shortened to txa) is a medicine that controls bleeding. It helps your blood to clot and is used for nosebleeds and heavy periods. If you're having a tooth taken out, using tranexamic acid mouthwash can help stop bleeding. Contraindication: Hypersensitivity. Active thromboembolic disease (e.g. pulmonary embolism, DVT, cerebral thrombosis), history or risk of thromboembolism (including retinal vein or artery occlusion); fibrinolytic conditions after consumption coagulopathy (unless predominant 66 muscle pains or stiffness. anaphylaxis or anaphylactoid reaction), venous and arterial thrombosis or thromboembolism; cerebral oedema and infarction (particularly in women with subarachnoid haemorrhage), dizziness. Blood and lymphatic system disorders: Anaemia. Gastrointestinal disorders: Nausea, vomiting, diarrhoea, abdominal pain. General disorders and administration site conditions: Fatigue. Musculoskeletal and connective tissue disorders: Musculoskele tal pain, back pain, muscle cramps or spasm, arthralgia. Nervous system disorders: Headache, migraine. Respiratory, thoracic and mediastinal disorders: Nasal and sinus symptoms. Skin and subcutaneous 3. Tranexamic Acid should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed. 4. The medication can be taken with or without meals. 5. Swallow Tranexamic Acid whole with plenty of liquids. Do not break, crush, or chew before swallowing. 6. If you miss a dose of Tranexamic Acid, take it when you remember, then take your next dose at least 6 hours later. Do not take 2 doses at once. 7. Inform the client that he/she should inform the physician immediately if severe side effects occur activation of the fibrinolytic system with acute severe bleeding), history of convulsions; acquired disturbances of color vision. Severe renal impairment. Concomitant use with combined hormonal contraceptives. 67 tissue disorders: Allergic dermatitis. VIII. DATE AND TIME COURSE IN THE WARD DOCTOR’S ORDER January 23, 2023 FOCUS Admission 10:00PM DATA, ACTION, RESPONSE D: The patient was rushed to the emergency room due to a motor vehicular accident. The patient was in a groggy state with some abrasions on his right hand, both arms, right upper leg, left lower leg, and on his right cheek. T: 35.8 PR: 129 bpm RR: 38 bpm BP: 60/40 mmHg O2Sat: 90% GCS: E3V4M5 A: The patient was immediately resuscitated by the nurses on duty following the ABC procedure. Oxygen was also administered at 10 lpm via face mask as ordered by the physician. 10:20PM - PNSS 1L 1 PRBC Laboratory and Diagnostics: - Blood Typing and crossmatching RAT Blood Transfusion D: The patient was seen pale and had cool skin when touched. D:. Blood type: O+ A: A pack of RBC was transfused to the patient via the CVC right femoral vein. A: PNSS 1L fast drip was also administered through the right cephalic vein. D: The patient was grimacing while holding his abdomen. A large, bluish-purplish bruise was seen on the patient’s right upper abdomen with a pain scale of 8/10. 10:30PM A: A FAST ultrasound was done on the patient. R: The ultrasound indicates that there was a large amount of blood present in the patient’s peritoneal cavity. 10:40PM A: Orders were carried out Laboratory and Diagnostics: - R: CBC result showed hemoglobin of 120 g/L, hematocrit of 30%, WBC of 6.9 x10^9/L, and blood pH of 7.20. CBC ECG Blood Che A: Medico-Legal was assessed and done 11:00PM R: The patient has multiple abrasions on his right hand, arms, right upper leg, left lower leg, and right cheek. A large, bluishpurplish bruise on his right upper quadrant of the abdomen was also seen. January 24, 2023 - 12:00AM - For emergency exploratory laparotomy Administer anesthetics Preoperative care D: The patient was transferred to the OR for an emergency exploratory laparotomy. A: Oriented to the OR unit, OR 69 consent form was secured. surgical checklist was assessed and done, IFC was inserted aseptically, preoperative medications were administered, seen and examined by the surgeon and anesthesiologist, VS was carefully monitored. D: 980 ml of blood was evacuated in the patient’s peritoneal cavity. The surgeon located the source of bleeding which was the liver particularly on the right hepatic artery, which graded as V with laceration and parenchymal disruption involving 75% of the hepatic lobe. 1:00AM A: Perihepatic packing on the right upper quadrant of the patient’s liver was done. R: The pack was left on the patient’s liver for 48 hours. 3:30AM - Transfer to PACU PACU transfer and Monitor VS every 15 continuous monitoring minutes Keep NPO until return of peristalsis D: The procedure was done. The patient was transferred to the PACU. T: 36.6 PR: 100 bpm RR: 23 bpm BP: 110/80 mmHg O2Sat: 97% 3:45AM Continuous Monitoring 70 D: The patient was still groggy, positioned flat on bed. VS monitored closely, assessed for signs of anesthesia wearing off like return of peristalsis and ability to move feet. IFC was intact, draining well, above IVF was infusing well. T: 36.6 PR: 100 bpm RR: 23 bpm BP: 110/80 mmHg O2Sat: 97% 4:00AM - Discontinue oxygen 10 lpm via facemask A: Oxygen was discontinued. A: VS monitored closely, assessed for signs of anesthesia wearing off like return of peristalsis and ability to move feet. R: The patient was able to raise his both feet to a desirable level. 5:00AM - Transfer to ICU D: The patient was transferred to the ICU for close monitoring. 5:30AM - Laboratory Test: ABG D: The patient was seen sleeping. IFC was intact, draining well, above IVF was infusing well. T: 36.8 PR: 125 bpm RR: 23 bpm BP: 110/70 mmHg O2Sat: 97% A: Orders were carried out. 71 R: Blood pH was decreased to 7.20, HCO3: 18. The patient was experiencing metabolic acidosis. 5:35AM - - 6:00AM - A: Sodium bicarbonate IV was administered to the patient. 1 PRBC was transfused to the patient via CVC right femoral vein. Sodium bicarbonate 2-5 mEq/kg IV over 4-8 hrs 1 PRBC Benzylpenicillin 125mg, IV, Q6 Continuous Monitoring D: The patient was asleep. IFC was intact, draining well, above IVF was changed aseptically. T: 36.8 PR: 100 bpm RR: 21 bpm BP: 110/80 mmHg O2Sat: 97% A: Administered Benzylpenicillin 125mg, IV ANST (-) as ordered by the physician 7:00AM - Acetaminophen 500mg/50ml, IV Surgical Pain D: “Nararamdaman po sumasakit yung tahi ko” as verbalized by the patient. Pain scale of 7/10, face mask of pain, restlessness. A: Instructed use of distraction imagery, deep breathing exercises, Acetaminophen 500mg/50ml, IV was administered as ordered by the physician. R: Patient stated “hindi na po gaano masakit”. Pain 72 scale of 3/10 9:00AM Wound Care D: The patient was conscious, lying comfortably on the bed. A: Wound care done, IFC was intact, draining well, above IVF was infusing well. 10:00AM Continuous Monitoring D: The PRBC bag of the patient was already consumed. T: 36.6 PR: 89 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% A: Blood transfusion line of the patient was removed aseptically R: 1 PRBC was transfused to the patient. 12:00AM - Benzylpenicillin 125mg, IV, Q6 A: Administered Benzylpenicillin 125mg, IV as ordered by the physician 1:00PM - Acetaminophen 500mg/50ml, IV Sodium bicarbonate 2-5 mEq/kg IV over 4-8 hrs D: The patient was seen lying on his bed. IFC was intact, draining well, above IVF was infusing well. - A: Administered Acetaminophen 500mg/50ml, IV, and Sodium bicarbonate 2-5 mEq/kg IV, as ordered by the physician. 73 2:00PM Continuous Monitoring D: The patient was asleep. IFC was intact, draining well, above IVF was changed aseptically. T: 36.8 PR: 92 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% 6:00PM - D: The patient was seen lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 10:00PM Continuous Monitoring D: The patient was asleep. IFC was intact, draining well, above IVF was changed aseptically. T: 36.7 PR: 87 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% January 25, 2023 - 12:00AM - D: The patient was seen lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the 74 physician. 6:00AM Continuous Monitoring D: The patient was asleep. IFC was intact, draining well, above IVF was changed aseptically. T: 36.7 PR: 87 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% 6:15AM - D: The patient was seen lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. D: The patient was seen and examined by Dr. A. 9:30AM A: Wound care done, assisted on early ambulation. IFC was intact, draining well, above IVF was infusing well. 10:00AM - A: All orders were carried out. Laboratory Test: PT, PTT, CBC R: Laboratory test shows PT: 12.5 sec, PTT: 27.8 sec. Hgb: 130 g/L, Hct: 35%, WBC: 5x10^9/L, blood pH: 7.35 10:30AM Continuous Monitoring 75 D: The patient was seen conscious, lying on his bed. IFC was intact, draining well, above IVF was infusing well. T: 36.8 PR: 92 bpm RR: 20 bpm BP: 110/70 mmHg O2Sat: 97% 12:00PM - D: The patient lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 2:00PM Continuous Monitoring D: The patient was asleep. IFC was intact, draining well, above IVF was changed aseptically. T: 36.7 PR: 87 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% 6:00PM - D: The patient lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 76 10:00PM - D: The patient was seen lying on his bed. IFC was intact, draining well, above IVF was infusing well. NPO for 8 hours T: 36.8 PR: 89 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% A: Instructed the patient to eat nothing by mouth until tomorrow for the scheduled surgery. R: The patient understood the instructions. January 26, 2023 - 12:00 am - D: The patient lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV, as ordered by the physician. 8:00 am - D: The patient was seen lying on his bed. IFC was intact, draining well, above IVF was infusing well. Remain NPO Laboratory Test: ABG T: 36.8 PR: 89 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% A: Orders were carried out. R: ABG result 77 showed blood pH of 7.37, HCO3 of 25. 10:00AM - For second-look laparotomy Preoperative care D: The patient was transferred to the OR for a secondlook laparotomy. A: Oriented to the OR unit, OR consent form was secured. surgical checklist was assessed and done, IFC was inserted aseptically, preoperative medications were administered, seen and examined by the surgeon and anesthesiologist; and VS was carefully monitored. D: The patient’s abdomen was washed out, the perihepatic packing was carefully removed, the right hepatic artery was avulsed and thrombosed, and it was ligated. 11:30AM 12:00PM - Benzylpenicillin 125mg, IV, Q6 A: Administered Benzylpenicillin 125mg, IV, as ordered by the physician. 12:30PM - Transfer to PACU PACU transfer and Monitor VS every 15 continuous monitoring minutes Keep NPO until return of peristalsis D: The procedure was done. The patient was transferred to the PACU. - T: 36.8 PR: 89 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% 78 12:45PM Continuous Monitoring D: The patient was positioned flat on bed. VS monitored closely, assessed for signs of anesthesia wearing off like return of peristalsis and ability to move feet. IFC was intact, draining well, above IVF was infusing well. T: 36.6 PR: 100 bpm RR: 23 bpm BP: 110/80 mmHg O2Sat: 97% 2:00PM Continuous Monitoring D: The patient was positioned flat on bed. VS monitored closely, IFC was intact, draining well, above IVF was infusing well. The patient was able to raise his both feet at a desired level. T: 36.6 PR: 100 bpm RR: 22 bpm BP: 110/80 mmHg O2Sat: 97% 2:30PM - Transfer to surgery ward Monitor VS every 4 hours D: The patient was transferred to the surgery ward. IFC was intact, draining well, above IVF was infusing well. T: 36.6 PR: 100 bpm RR: 23 bpm BP: 110/80 mmHg O2Sat: 97% 79 5:00PM - Acetaminophen 500mg/50ml, IV Surgical Pain D: The patient was seen conscious, with a facial mask of pain, restlessness, “Medyo nararamdaman ko yung sakit sa opera ko” as stated by the patient. Pain scale of 7/10 A: Instructed use of distraction imagery, deep breathing exercises, Acetaminophen 500mg/50ml, IV was administered as ordered by the physician. R: Patient stated “hindi na po gaano masakit”. Pain scale of 3/10 6:00PM - Benzylpenicillin 125mg, IV, Q6 Continuous Monitoring D: The patient was lying on his bed. VS monitored closely, IFC was intact, draining well, above IVF was infusing well. T: 36.6 PR: 100 bpm RR: 22 bpm BP: 110/80 mmHg O2Sat: 97% A: Benzylpenicillin 125mg, IV was administered. 6:30PM - A: All orders were carried out. Laboratory Test: CBC, Serum Electrolytes test, Blood Chemistry 10:00PM Continuous Monitoring 80 D: The patient was asleep. VS monitored closely, IFC was intact, draining well, above IVF was infusing well. T: 36.6 PR: 100 bpm RR: 22 bpm BP: 110/80 mmHg O2Sat: 97% January 27, 2023 - 12:00AM - D: The patient lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 6:00AM Continuous Monitoring D: The patient was still asleep. IFC was intact, draining well, above IVF was changed aseptically. T: 36.7 PR: 87 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% 6:30AM - D: The patient lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 7:00AM - A: Diet was implemented. Clear liquid diet 9:30AM Wound care 81 D: The patient was conscious, lying comfortably on the bed. A: Wound care done, IFC was intact, draining well, above IVF was infusing well. R: Patient’s abrasion wounds started to dry and heal. 10:00AM Continuous Monitoring D: The patient was lying on his bed. IFC was intact, draining well, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 20 bpm BP: 110/80 mmHg O2Sat: 97% A: Instructed and assisted the patient for early ambulation. R: The patient understood the instructions. 12:00PM - D: The patient lying on his bed. IFC was intact, draining well, above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 1:00PM - A: IFC was removed aseptically. Remove IFC aseptically after return of voiding sensation 2:00PM Continuous Monitoring 82 D: The patient was using his phone, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% 6:00PM - D: The patient lying on his bed., above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 10:00PM Continuous Monitoring D: The patient was asleep, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% January 28, 2023 - 12:00AM - D: The patient lying on his bed., above IVF was infusing well. Acetaminophen 500mg/50ml, IV Benzylpenicillin 125mg, IV, Q6 T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg 83 O2Sat: 97% A: Administered Acetaminophen 500mg/50ml, IV and Benzylpenicillin 125mg, IV as ordered by the physician. 6:00AM - Benzylpenicillin 125mg, IV, Q6 Continuous Monitoring D: The patient was asleep, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% A: Administered Benzylpenicillin 125mg, IV as ordered by the physician. 9:00AM - Discontinue Acetaminophen 500mg/50ml, IV Wound care D: The patient was seen and examined by Dr. A. A: Wound care done, draining well, above IVF was infusing well. 10:00AM Continuous Monitoring D: The patient was asleep, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% 12:00PM - A: Administered Benzylpenicillin 125mg, IV as ordered by the physician. Benzylpenicillin 125mg, IV, Q6 84 2:00PM Continuous Monitoring D: The patient was watching on his phone, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% 6:00PM - D: The patient was watching on his phone, above IVF was infusing well. . Benzylpenicillin 125mg, IV, Q6 T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% A: Administered Benzylpenicillin 125mg, IV as ordered by the physician. 10:00PM Continuous Monitoring D: The patient was watching on his phone, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% January 29, 2023 12:00AM - A: Administered Benzylpenicillin 125mg, IV as ordered by the physician. Benzylpenicillin 125mg, IV, Q6 6:00AM Continuous Monitoring 85 D: The patient was watching on his phone, above IVF was infusing well. . T: 36.7 PR: 87 bpm RR: 19 bpm BP: 110/80 mmHg O2Sat: 97% 8:00AM - A: All orders were carried out. Laboratory Test: CBC, Serum Electrolytes test, Blood Chemistry, Urinalysis, Fecalysis 9:30AM Wound care A: Wound care done, draining well, above IVF was infusing well. 10:00AM Discharge Planning D: All laboratory results shows normal values. A: The patient was seen and examined by Dr. A with orders made and carried out, with may go home order, instructed SO to settle hospital bills, gave instructions on home medications, emphasized checkup after 1 week, above IVF removed aseptically. R: Acceded to all instructions, settled bills, and went home accompanied by his SO. 86 IX. NURSING CARE PLAN ASSESSMENT NURSING DIAGNOSIS SCIENTIFIC EXPLANATION PLANNING NURSING INTERVENTION Subjective Data: "Hindi ako makahinga ng maayos", as verbalized by the patient. Ineffective tissue perfusion related to blood loss Major bleeding ⬇ Decreased venous return ⬇ Decreased preload ⬇ Decreased cardiac output ⬇ Poor tissue perfusion Short term goal: After 8 hours of nursing interventions, the patient will demonstrate increased perfusion as evidenced by an increasing blood pressure and decreasing pulse and respiratory rate Independent: Objective Data: •Tachypneic •Capillary refill greater than 3 seconds •Poor skin turgor •Vital signs: >T: 35.8°C >P: 129 bpm >R: 38 cpm >BP: 60/40 >O2: 90% Long term goal: After 1 week of nursing interventions, the patient will have optimal perfusion as evidenced by: . vital signs within normal limits . capillary refill within 2 seconds . normal skin turgor 1. Monitor oxygen and arterial blood gas RATIONALE EVALUATION 1. As shock progresses, lactic acidosis occurs resulting in the increased level of carbon dioxide and decreasing pH. Short term goal: After 8 hours of nursing interventions, the goal was met as evidenced by a blood pressure of 90/60, pulse rate of 104 bpm, and respiratory rate of 25 cpm 2. Restrict the patient’s activity and maintain the client on bed rest. 2. Minimizes oxygen demand 3. Administer IV fluids 3. Sufficient fluid intake maintains adequate filling pressures and optimizes cardiac output needed for tissue perfusion Dependent: 1. Provide 10 lpm via face mask, as indicated. 1. To support oxygenation and perfusion Long term goal: After 1 week of nursing interventions, the goal was met as evidenced by: . blood pressure:110/80 mmHg, pulse rate: 86 bpm, respiratory rate of 20cpm, and a temperature of 36.7°C . capillary refill within 2 seconds . normal skin turgor ASSESSMENT Subjective data: • "Masakit sa bandang tyan kong may pasa", as verbalized by the patient Objective Data: • Decreased urine output: 30ml • Dry mucous membranes • Cool, clammy skin • Poor skin turgor • Capillary refill greater than 3 seconds • Vital signs > T: 35.8°C > P: 129 bpm > R: 38 cpm > BP: 60/40 > O2: 90% NURSING DIAGNOSIS SCIENTIFIC EXPLANATION PLANNING Deficient Fluid Volume related to active fluid loss secondary to vehicular accident Vehicular Accident ⬇ Blunt trauma on upper abdominal cavity ⬇ Rupture of veins and capillaries ⬇ Major bleeding ⬇ Fluid volume deficit Short term goal: After 8 hours of nursing intervention the patient will able to have increased fluid volume as evidenced by an increasing blood pressure and decreasing pulse and respiratory rate Long term goal: After 1 week of nursing intervention the patient will able to have adequate fluid volume as evidenced by: . stable vital signs . warm and dry skin . moist mucous membranes . normal skin turgor . capillary refill within 2 seconds 88 NURSING INTERVENTION Independent: 1. Monitor vital signs 2. Auscultate heart tones and inspect jugular veins 3. Assess mental status Dependent: 1. Start intravenous fluid replacements, as ordered 2. Administer 1 PRBC, as ordered. RATIONALE EVALUATION 1. Serve as baseline data and for comparison, especially with active blood loss Short term goal: After 8 hours of nursing intervention the goal was met as evidenced by a blood pressure of 90/60, pulse rate of 104 bpm, and respiratory rate of 25 cpm 2. Abnormally flattened jugular veins and distant heart tones are signs of ineffective circulation Long term goal: After 1 week of nursing intervention the goal was met as evidenced by: . blood 3. Loss of pressure:110/80 consciousness mmHg, pulse accompanies rate: 86 bpm, ineffective circulating respiratory rate of blood volume to the 20cpm, and a brain temperature of 36.7°C . warm and dry 1. Parenteral fluids skin are necessary to . moist mucous restore volume membranes quickly. . normal skin turgor . urine output of 2. Blood and blood 1200ml products will be . ASSESSMENT Subjective Data: “Ang dami kong gasgas sa katawan”, as verbalized by the patient. Objective Data: • Abrasions that are superficial in depth and with a size of: >Left cheek: 2cm >Right hand: 2cm >Right arm: 3.5cm >Left arm: 3cm >Right upper leg: 3.5cm >Left lower leg: 3cm normal urine output per hour necessary to replace blood loss NURSING DIAGNOSIS SCIENTIFIC EXPLANATION PLANNING NURSING INTERVENTION Impaired skin integrity related to multiple abrasions secondary to vehicular accident Vehicular Accident ⬇ Friction against a rough surface ⬇ Multiple abrasion ⬇ Damaged skin tissue ⬇ Impaired skin integrity Short term goal: After 1 hour of nursing interventions, the patient will demonstrate measures to heal and protect wound, including wound care Independent: 1. Monitor the site of impaired tissue integrity at least once daily for color changes, redness, swelling, warmth, pain, or other signs of infection. Long term goal: After 1 week of nursing interventions, the patient's wound will decrease in size 2. Encourage a diet that meets nutritional needs. 3. Teach skin and wound assessment and ways to monitor for signs and symptoms of infection, complications, and healing. 89 RATIONALE 1. Systematic inspection can identify impending problems early. 2. A high-protein, high calorie diet may be needed to promote healing (ex. Yogurt,eggs, mashed potatoes, soft cooked beans etc.) 3. Early assessment and intervention help prevent the development of serious problems. EVALUATION Short term goal: After 1 hour of nursing interventions, the goal was met as evidenced by demonstration of measures to heal and protect wound, including wound care Long term goal: After 1 week of nursing interventions, the goal was met as evidenced by a decrease in wound size 4. Instruct the patient and significant other the proper care of the wound including hand washing, wound cleansing, dressing changes, and application of topical medication. 5. Educate the patient on the need to notify physician. ASSESSMENT NURSING DIAGNOSIS SCIENTIFIC EXPLANATION PLANNING Subjective Data: "Masakit yung tahi ng tyan ko", as verbalized by the patient with a rate of 6/10 Acute pain related to surgical incision site as evidenced by pain scale of 6/10, facial grimace and guarding behavior Surgical incision of the abdomen Short term goal: After 2 hours of nursing interventions, the patient will verbalize a decrease in pain as evidenced by decrease in pain scale from 6/10 to 1-2/10 Objective Data: •Abdominal incision •Facial grimace •Guarding behavior ⬇ Tissue trauma ⬇ Pain perception Long term goal: After 5 days of nursing intervention, the patient will be relieved from pain as evidenced by: 90 4. Accurate information increases the patient’s ability to manage therapy independently and reduce risk for infection. 5. This is to prevent further complications. NURSING INTERVENTION Independent: 1. Observe and document location and severity of pain. RATIONALE 1. Assist in differentiating cause of pain, and provides information about disease progression, development of complication and effectiveness of intervention. EVALUATION Short term goal: After 2 hours of nursing interventions, the goal was met as evidenced by decrease in pain scale from 6/10 to 2/10 Long term goal: After 5 days of nursing intervention, the goal was met as evidenced by: . verbal report of pain absence . verbal report of pain absence . relaxed appearance with no facial grimace and guarding behavior 2. Note response to medication and report to physician if pain is not being relieved. 3. Provide a quiet environment and encourage patient to rest. 1. Perform nonpharmacol ogic pain relief methods such as relaxation techniques and provision of distractions Dependent: 1. Administer acetaminophen 500mg/50ml IV, as prescribed. 91 2. Severe pain not relieved by routine measures may indicate developing complication or need for further intervention. 3. Additional stressors can intensify the patient’s perception and tolerance of pain. 3. To provide optimal comfort to the patient. 1. To alleviate and relieve pain . relaxed appearance with no facial grimace and guarding behavior ASSESSMENT NURSING DIAGNOSIS SCIENTIFIC EXPLANATION Subjective Data: • “Katatapos lang ako inoperahan, may tahi ako dito sa tyan", as verbalized by the patient Risk for infection related to break in skin integrity secondary to surgical procedure Surgical incision ⬇ Pathogens may invade the incision ⬇ Pathogens will multiply at the site of surgical wound ⬇ Infection Objective Data: • Surgical incision on abdomen PLANNING Short term goal: After 30 minutes of nursing interventions, the patient will be able to demonstrate proper wound cleaning and dressing. Long term goal: After 1 week of nursing interventions, the patient will remain free of infection NURSING INTERVENTION Independent: 1. Assess signs and symptoms of infection, especially temperature 1. Increase in temperature may indicate infection EVALUATION Short term goal: After 30 minutes of nursing interventions, the goal was met as evidenced by demonstration of proper wound cleaning and dressing. 2. Emphasize the importance of handwashing technique 2. It serves as first line of defense against infection 3. Maintain aseptic technique when changing dressing or caring for wound, and in disposing contaminated waste. 3. Regular wound dressing promotes fast Long term goal: After 1 week of healing and drying of nursing wound. interventions, the goal was met as evidenced by the 4. Wet area can be client remaining free lodge area for bacteria of infection 4. Keep wound area clean and dry 5. Encourage nutritional intake rich in calories and protein, vitamins, and carbohydrates Dependent: 1. Administer Benzylpenicillin 125 mg IV q8, as prescribed. 92 RATIONALE 5. An adequate amount of calories helps the body use nutrients to build a strong immune system and protein helps with wound healing 1. Aids in preventing the client from acquiring infection X. REFERENCES Exploratory Laparotomy. (2023). Saint Luke’s Health System. https://www.saintlukeskc.org/health-library/exploratory-laparotomy Wikipedia Contributors. (2022, September 21). Perihepatic packing. Wikipedia; Wikimedia Foundation. https://en.wikipedia.org/wiki/Perihepatic_packing Wikipedia Contributors. (2023, January 29). Central venous catheter. Wikipedia; Wikimedia Foundation. https://en.wikipedia.org/wiki/Central_venous_catheter Doklestić, K., Stefanović, B., Gregorić, P., Ivančević, N., Lončar, Z., Jovanović, B., Bumbaširević, V., Jeremić, V., Vujadinović, S. T., Stefanović, B., Milić, N., & Karamarković, A. (2015). Surgical management of AAST grades III-V hepatic trauma by Damage control surgery with perihepatic packing and Definitive hepatic repair–single centre experience. World Journal of Emergency Surgery, 10(1). https://doi.org/10.1186/s13017-015-0031-8 Caruso, D. M., Battistella, F. D., Owings, J. T., & Samaco, R. C. (1999, October). Perihepatic Packing of Major Liver Injuries: Complications and Mortality. ResearchGate; American Medical Association. https://www.researchgate.net/publication/12811805_Perihepatic_Packing_of_Major_Liver_Injuri es_Complications_and_Mortality and, D. (2023, February). Your Digestive System & How it Works. National Institute of Diabetes and Digestive and Kidney Diseases; NIDDK | National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/digestive-diseases/digestivesystem-how-it-works Liver Functions, Location, Anatomy and Disease | Columbia Surgery. (2022). Columbiasurgery.org. https://columbiasurgery.org/liver/liver-and-its-functions Philbert Yuan Van. (2021, June 7). Liver Injury. MSD Manual Consumer Version; MSD Manuals. https://www.msdmanuals.com/home/injuries-and-poisoning/abdominal-injuries/liver-injury Introduction to the Cardiovascular System | SEER Training. (2023). Cancer.gov. https://training.seer.cancer.gov/anatomy/cardiovascular/ Hoffman, M. (2010, April 27). Picture of Blood. WebMD; WebMD. https://www.webmd.com/heart/anatomy-picture-of-blood Belleza, M. (2017, August 15). Blood Anatomy and Physiology: Study Guide for Nurses. Nurseslabs. https://nurseslabs.com/blood-anatomy-physiology/ Khan Academy. (2023). Khanacademy.org. https://www.khanacademy.org/science/biology/human-biology/circulatorypulmonary/a/components-of-the-blood Bleeding: MedlinePlus Medical Encyclopedia. (2014). Medlineplus.gov. https://medlineplus.gov/ency/article/000045.htm Taghavi, S., & Askari, R. (2022, July 19). Liver Trauma. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513236/#:~:text=Liver%20trauma%20can%20run%20t he,of%20Trauma%20Hepatic%20Injury%20Scale. Philbert Yuan Van. (2021, July). Hepatic Injury. MSD Manual Professional Edition; MSD Manuals. https://www.msdmanuals.com/professional/injuries-poisoning/abdominaltrauma/hepatic-injury Health, U. (2020, December 22). Liver Injuries & Home Care. Ucsfbenioffchildrens.org; UCSF Health. https://www.ucsfbenioffchildrens.org/education/liver-injuries-and-home-care Ahmed, N., & Vernick, J. (2011). Management of liver trauma in adults. Journal of Emergencies, Trauma, and Shock, 4(1), 114. https://doi.org/10.4103/0974-2700.7684 94 95